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Sialic Acid Modulation Of Cardiac Voltage-Gated Sodium Channel Gating
Throughout The Developing Myocardium
Patrick J. Stocker
ABSTRACT

The proper orchestration of voltage-gated ion channel gating is vital to
maintaining normal heart rhythms throughout an animal’s lifespan. Voltagegated sodium channels, Nav, are responsible for the initiation of the cardiac
action potential, which leads to cardiac systole. Comparison of neonatal
ventricular and atrial myocyte Nav gating with adult indicated that the neonatal
ventricular Nav gated following a ~10 mV greater depolarization than did atrial or
adult ventricular Nav. In this study I questioned whether development- and/or
chamber-dependent changes in Nav-associated functional sialic acids could
account for these differences. When desialylated with neuraminidase, all gating
characteristics for the lower voltage activated atrial and adult ventricular Nav
shifted significantly to more depolarized potentials. However, desialylation of the
higher voltage activated neonatal ventricular Nav had no effect on channel gating.
Furthermore, channels were stripped of their N-glycosylation via PNGase-F in an
attempt to separate the potential effects of the remaining glycosylation structure
on Nav gating. Following treatment, neonatal ventricular Nav gating remained
unchanged while atrial and adult ventricular Nav gating again shifted to
viii

depolarized potentials nearly identical to those of the neonatal ventricular
channel. Immunoblot analyses indicated that atrial and adult ventricular Nav α
subunits are more heavily sialylated than the neonatal ventricular α subunit, with
approximately 15 more sialic acid residues. The data indicate that differential
sialylation of myocyte Nav α subunits is responsible for much of the
developmental and chamber-specific remodeling of Nav gating observed here. In
addition, the Nav1.5 α subunit can associate with β subunits, also believed to be
sialylated. The potential for functional β1 trans sialic acids to further modulate
Nav1.5 gating was tested via co-transfection of β1 with the Nav1.5 α subunit into the
Pro5/Lec2 mammalian expression system. Co-transfection revealed that the
additional β1 trans sialic acids caused a hyperpolarizing shift in all tested gating
parameters. When transfected into neonatal ventricular myocytes, β1 expression
revealed no effect, implying that β1 expression alone is not responsible.
Together, the myocyte and expression system studies describe a novel
mechanism by which Nav gating, and subsequently cardiac excitability, are
modulated by the regulated change in channel-associated functional sialic acids.
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Introduction

Ion transport
Ion transport from one side of a cell membrane to another is an important
element in many processes like nerve transduction, muscle contraction (cardiac,
skeletal, smooth), neurotransmitter release, nutrition absorption, and
maintenance of the cellular membrane potential. To accomplish this movement
of ions many different protein mediated transport mechanisms such as ion
exchange, active transport, secondary active transport, leak, stretch-activated,
ligand-gated, and voltage-gated ion channels exist.
For ion exchange mechanisms, each set of ions move down their
electrochemical gradient, produced through the combination of the ion’s
concentration gradient and electrical driving force. Some popular examples of
these transporters are Na+ / Ca2+, Cl- / HCO3-, and Na+ / H+ exchangers (figure 1).
The transport protein in question associates with its specific ions on each side of
the membrane and then the ions are swapped from one side to the other. Active
transport is the movement of solutes from one side of the membrane to the other
against that solute’s concentration gradient. Fueled by the hydrolysis of ATP, the
Na+ / K+ ATPase helps to maintain a cell’s resting membrane potential, regulated
by intra and extracellular Na+ and K+ concentrations, by transporting three Na+
outside and two K+ inside the cell (figure 2). Secondary active transport is fueled
1

Figure 1: Ion exchange transport proteins
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Figure 1: (continued)
Facilitated transport proteins exchange one ion for another from one side of the
membrane to the other.
A: Na+ / Ca2+ ion exchanger
B: Cl- / HCO3- ion exchanger
C: Na+ / H+ ion exchanger
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Figure 2: Active transport
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Figure 2: (continued)
A schematic example of active transport using the Na+/K+ ATPase to move Na+
and K+ against their concentration gradients.
Step 1: Na+ binds to the cytoplasmic open face of the transport protein. Step 2:
ATP is hydrolyzed to ADP phosphorylating the protein. Step 3: The Na+ bound
phosphorylated protein opens to the outside releasing the Na+. Step 4: K+ binds
to the open extracellular face of the phosphorylated transport protein. Step 5:
The protein becomes unphosphorylated. Step 6: The unphosphorylated protein
opens to cytoplasmic side of the membrane releasing the K+ allowing for the
cycle to start again.
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by the energy resulting from one solute’s movement from one side of the
membrane to the other down its chemical gradient. This supplied energy is used
to co-transport other solute molecules against their chemical gradients, as in the
case of glucose absorption in the gut and kidneys together with Na+ ions (figure
3).
Ion channels are a second type of transmembrane protein that creates
permeation pathways for ions to cross membranes. These proteins form
aqueous pores in the membrane that, with the use of a selectivity filter, allow
specific ions to pass through from one side of the membrane to the other. When
an ion is allowed to pass through a channel, it flows down its electrochemical
gradient requiring no energy expenditure. Ion channels fall into four general
categories based on their mode of activation, leak, stretch-activated, ligandgated, and voltage-gated. Leak channels are exactly that, channels that are
believed to be constitutively active. Typically involved in maintaining the resting
membrane potential, leak channels are active most of the time creating a
permeation pathway for a specific ion (Plant et al., 2005;Tamargo et al., 2004).
Stretch-activated channels are believed to open in response to plasma
membrane stretch. Once stretched the protein changes conformation to create
an aqueous pore through which ions can flow. Their functions are not totally
understood but are believed to be involved in the regulation of cell volume
(Zagorodnyuk et al., 2005;Kalapesi et al., 2005;Trayanova et al., 2004). Ligandgated channels are thought to be closed at rest; following binding of a ligand to
the channel, neurotransmitters for example, the channel opens (figure 4).
6

Figure 3: Secondary active transport of Na+ and glucose in the small intestine
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Figure 3: (continued)
Co-transport of one molecule accomplished by using the energy released
through the transport of a second molecule.
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Figure 4: Neuromuscular junction
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Figure 4: (continued)
Close up illustration of the neuromuscular junction showing Acetylcholine being
released from the axon and traveling across the synapse to the ligand-gated Ach
receptor binding sites to thus result in channel opening and eventual muscle
contraction.
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Acetylcholine (Ach) receptors at the neuromuscular junction are a good example
of ligand-gated ion channels. Ach is released by the motor neuron into the
synapse and becomes bound to motor endplate Ach receptors changing them
from closed to open. Once Na+ moves down its electrochemical gradient
depolarizing the membrane this depolarization then triggers what are known as
voltage-gated ion channels. Voltage-gated ion channels are membrane proteins
that open in response to a membrane depolarization. Typically, when a cell
membrane is at its resting membrane potential, the channel is in its closed
conformation. When the membrane becomes more depolarized the channel
senses this change in potential, opens, then allows selected ions to pass
through. Following the open state most voltage-gated ion channels then rapidly
close, voltage-gated K+ channels for example, while others move into a third
state called inactivation, voltage-gated Na+ channels for example, rendering it
unlikely for the channel to then be reactivated (figure 5). Once the Ach receptor
induced Na+ mediated membrane depolarization opens the voltage-gated Na+
channels, Na+ moves down its electrochemical gradient through the open
channels into the cell further depolarizing the surrounding membrane. When the
membrane potential has become depolarized enough to reach what is known as
the threshold potential, an action potential is the result. Once an action potential
has been triggered, the membrane depolarization spreads to the surrounding
areas and has a similar effect on the voltage-gated ion channels in the area, thus
propagating the signal and ultimately resulting in muscle contraction. In addition,
the membrane depolarization of the spreading action potential has now also
11

Figure 5: Schematic representation of a voltage-gated Na+ channel
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Figure 5: (continued)
In segment A is a voltage-gated Na+ channel in the closed state. When moving
to segment B the membrane begins to become depolarized being sensed by the
channel voltage sensors. In segment C the channel has moved from the closed
to the open state allowing Na+ to flow through. Following segment C for some
channels, K+ for example, the channel would then move back into the closed
state ready to be used again. In this case, the Na+ channel moves into a third,
inactivated state (segment D) when a channel inactivating segment blocks the
open channel pore. Following membrane repolarization the channel moves back
into the closed state, segment A, ready to refire again.
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activated voltage-gated K+ channels. This allows K+ to move out of the cell,
opposing the inward Na+ current, repolarizing the membrane back to its resting
potential and resetting the system to receive and transmit further signals.

Voltage-gated Na+ channels
Voltage-gated Na+ channels, Nav, are responsible for the initiation and
propagation of action potentials in excitable tissues, opening rapidly and then
inactivating following a membrane depolarization (Hille, 2001). The orchestrated
activation and inactivation of Na+ channels is vital to normal skeletal muscle and
neuronal function, and in maintaining normal heart rhythm. To date ten different
voltage-gated Na+ channel isoforms have been identified. Nav nomenclature
derived to identify the different isoforms is Nav1.1 to Nav1.9 with the tenth being
labeled Nax (figure 6) (Goldin et al., 2000). Each Nav isoform shares greater than
50% identity with the other Nav family members. One important fact to note
when considering the following description is that, to date, no one has been able
to crystallize a voltage-gated Na+ channel in its complete membrane incorporated
functional quaternary structure. This current limitation has led to a generally
agreed upon structure of functional membrane bound voltage-gated Na+
channels as elucidated from the efforts of channel biologists worldwide. Nav are
sodium specific ion channels that are made up of a single polypeptide chain
forming the α subunit. This chain weaves in and out of the membrane twentyfour times forming 4 distinct domains made up of six membrane-spanning
segments each (figure 7). The S4 segment of each domain contains a positively
14

Figure 6: A chart outlining the known voltage-gated Na+ channel α subunits
along with their corresponding anatomical locations (Goldin et al., 2000)
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Figure 7: Nav1.5 voltage-gated ion channel
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Figure 7: (continued)
Voltage-gated Na+ channels are made up of four homologous domains each with
six membrane spanning alpha helical segments with the fourth alpha helices
being the voltage sensors. The protein loops between each S5 and S6 segment
are believed to create the channel pore. The intracellular loop between the third
and fourth domain is the channel inactivation segment. Represented by pitchfork
structures on the large extracellular loop of the first domain are N-linked
glycosylation structures.
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charged amino acid in every third position. These S4 segments are believed to
make up what is referred to as the channel voltage sensor. The S4 amino acids
are thought to move from the inner surface of the membrane toward the outer
surface, repelled by the membrane depolarization, resulting in the conformation
change of the protein moving the channel from the closed to the open state. The
way in which the S4 segments are believed to be orientated and their motion in
response to a membrane depolarization has been a recent topic of debate. Over
the years it has been assumed that the S4 segments are embedded within the
quaternary structure in four cylindrically shaped alpha helices surrounding the
channel pore. Through work done studying crystallized segments of voltagegated K+ channels, which are homologous to Nav, it has now been suggested
that the S4 segments may actually form four paddle-like structures branching to
the outside of the channel rather than being embedded within it (Jiang et al.,
2003a;Jiang et al., 2003b). Regardless of their orientation, it is still believed that
the S4 segments are close to the inner membrane surface at rest moving
towards the outer surface following a membrane depolarization. The intracellular
linker between the third and the fourth domains is known as the fast inactivation
loop, made up of an IMF motif (isoleucine, methionine, phenylalanine). It is this
IMF motif of the loop that is believed block the channel pore moving it from the
open to inactivated state. During the inactivation period it is unlikely for the
channel to become opened again until the system is reset. Finally, for the
channel to move from the inactivated back to the closed state allowing the
channel to again be activated, the membrane must become hyperpolarized
18

again. The hyperpolarization of the membrane back to its resting potential drives
the channel to reset back to the closed state now ready to be used again. It is
important to recognize that this is a simplified description of Nav channel gating
and a more thorough explanation of the intricate details surrounding channel
gating can be found in many other literary works (e.g., Ion Channels of Excitable
Membranes, by Bertil Hille).

Ion channel glycosylation, sialic acid, and Nav
Ion channels are typically glycosylated when in their fully processed form.
Protein glycosylation occurs inside the ER and Golgi complex. Some protein
glycosylation requires activated carbohydrates as precursors while other forms
require oligosaccharide-pyrophosphoryldolichol. Activated carbohydrates are
ones that have reacted with UTP, CTP, or GTP, forming an XDP-carbohydrate
derivative. Once the reaction is complete, the activated sugar is transported
across the ER membrane via a transporter that exchanges XTP for XDPcarbohydrate. Once inside, the carbohydrate is transferred to the growing
glycoprotein chain by enzymes called glycosyl transferases. Other sugars are
transported into the ER by a carrier lipid (dolichol), which acts as an intermediate
in the reaction, forming the oligosaccharide-pyrophosphoryldolichol complex.
The overall process of protein glycosylation can typically be broken down into
two types, O-linked and N-linked glycosylation. The amino acid side chains to
which the carbohydrate group links defines each of the two types. In the case of
O-linked glycosylation, the sugars are attached to hydroxyl groups. In the case
19

of N-linked glycosylation, the sugars are attached to amino groups. With Olinked, either a single mannose or acetylgalactosamine residue is transferred
from an ER nucleotide carrier to the hydroxyl side chain of a serine, threonine,
hydroxyproline, or hydroxylysine amino acid. The completion of the O-linked
chain takes place in the Golgi complex with various sugars like
acetylgalactosamine, galactose, fucose, and sialic acid. To accomplish N-linked
glycosylation, two acetylglucosamine and nine mannose are attached to the ER
carrier lipid dolichol. Once assembled the sugar complex is transferred to an
asparagine residue that is followed by a serine or threonine. Once attached, the
protein is transferred to the Golgi where it becomes a high mannose, hybrid, or
complex N-linked glycoprotein through the addition of N-acetylglucosamine,
mannose, galactose, and or sialic acid (figure 8).
Voltage-gated Na+ channels contain complex N-linked glycosylation
structures. The defining characteristic of complex structures is that multiple sialic
acid branches cap them. Sialic acids are unique carbohydrates by virtue of the
fact that, under normal physiological conditions, they are the only sugars that are
charged, carrying a net -1 charge. All of this added negative charge surrounding
the voltage-gated channel may potentially exert an effect on channel gating. Up
to 35% of the total mass of many Nav may be attributed to carbohydrate (Cohen
& Levitt, 1993;Gordon et al., 1988;Roberts & Barchi, 1987;Schmidt & Catterall,
1987;Messner & Catterall, 1985). Up to 45% of these carbohydrates may be
composed of sialic acid residues, with around 100 or more sialic acid residues
attached to each α-subunit (Roberts & Barchi, 1987). Previous reports have
20

Figure 8: The three different types of known N-linked glycosylation structures
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Figure 8: (continued)
Attached to asparagine residues, there are three different types of N-linked
glycosylation structures that each shares the same base structure. Segment A is
high mannose N-linked glycosylation that terminates with multiple mannose
residues. Segment B is hybrid N-linked glycosylation terminating with a mixture
of mannose and galactose residues. Segment C is complex N-linked
glycosylation terminating with multiple sialic acid residues.
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indicated that sialic acid (SA) may play a role in channel function. Nearly
identical depolarizing shifts in Nav1.4 gating were observed using three
independent methods to reduce channel sialylation as expressed in CHO cells.
Chemical desialylation of the cardiac Nav α subunit (Nav1.5) expressed in HEK
293 cells resulted in depolarizing shifts in the voltage of half-activation, Va, while
a second study of Nav1.5 expressed in CHO cells reported no SA-dependent shift
(Bennett, 2002;Zhang et al., 1999). Because the effects of sialic acid on channel
gating vary with the expression system used, studies of Nav function in
cardiomyocytes would be the most direct means of addressing whether sialic
acid alters cardiac sodium channel gating.

The surface potential theory
The idea of a surface potential theory has been considered for around 50
years. The theory describes how fixed negative charges, at and around the ion
channel associated membrane surface, serve to create a negative surface
potential altering the electric field sensed by the channel voltage sensors. This
external negative surface potential acts to depolarize the membrane bringing the
Nav closer to its threshold potential for activation, thus affecting gating. The
establishment of a surface potential can be derived by many factors like sialic
acids, charged lipids making up the cell membrane, charged amino acids
comprising proteins, and electrolytic screening in solution. Changing [cation]o
has been shown to screen a suspected negative surface potential affecting Na+,
Ca2+, and K+ channel gating, with increasing concentrations causing channel
23

activation and inactivation to be shifted in the depolarized direction (Bennett et
al., 1997;Hahin & Campbell, 1983;Campbell & Hille, 1976;Dorrscheidt-Kafer,
1976;MOZHAYEV.GN & Naumov, 1970;BLAUSTEI.MP & Goldman, 1968;Hille,
1968;Hagiwara & Naka, 1964;Frankenhaeuser & Hodgkin, 1957;Weidmann,
1955). This phenomenon can be considered the divalent screening effect. This
translates into the need for a greater depolarization to enact channel activation in
the presence of elevated divalent cations levels. Sialic acid, being negatively
charged and so closely associated with the Nav, is an ideal candidate to be a
strong contributor to a negative surface potential.

The cardiac action potential and Nav
The cardiac action potential, the electrical signal that is spread across the
atria and ventricles resulting in cardiac systole, is accomplished through the
orchestrated opening and closing of voltage-gated sodium, potassium, and
calcium channels. The cardiac action potential (figure 9) consists of 5 phases
starting with phase 0. At phase 0 a propagating membrane depolarization from
neighboring cells elicits the opening of fast current voltage-gated Nav allowing
Na+ to rush into the myocyte, iNa, the membrane is depolarized to threshold and
an action potential begins. At the same time the Nav are activated, the rapid
membrane depolarization causes inward rectifier K+ channels to close, iK1i, and
then transient outward K+ channels open resulting in a brief membrane
repolarization, iTO, known as phase 1. Also at the start of phase 1, the Nav have
now begun to move into the inactivated state ending their role in the action
24

Figure 9: The cardiac action potential and current flow
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Figure 9: (continued)
Panel A is an example of a cardiac action potential with the five distinct parts
labeled from 0 - 4. Panel B outlines the various ionic currents making up the five
different parts of the action potential responsible for its shape and duration.
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potential. Phase 2 marks the plateau phase of the cardiac action potential. The
plateau phase results from the initial depolarization also causing the opening of
Ca2+ channels, iCa, that first counteract the decreasing iTO current. At the same
time, delayed rectifier K+ channels are activated, iK, that counteracts the
diminishing iCa after iTO stops bringing about the end of the plateau and the
beginning of phase 3. During phase 3 the remaining iK hyperpolarizes the cell
enough the cause the inward rectifier K+ channels to reopen, iK1, completely
repolarizing the cell back to its resting membrane potential maintained during
phase 4. The repolarization of the cell triggers the Nav from phase 0 to move
from their inactivated to closed states. Now the cell is ready to be refired once
more.
The primary voltage-gated sodium channels found in cardiac atrial and
ventricular myocytes, Nav1.5, are responsible for the initiation and propagation of
action potentials resulting in cardiac systole (figure 7). To date, expression of
Nav1.1, Nav1.3 Nav1.5 and Nav1.6 have been reported to be expressed in cardiac
tissue from animals such as rat, rabbit and mouse (Malhotra et al.,
2001;Baruscotti et al., 1997;Rogart et al., 1989). However, research from mice
has demonstrated that Nav1.5 appears to be the dominant current producing
cardiac Nav involved in the cardiac action potential phase zero (Lei et al.,
2004;Maier et al., 2002;Zimmer et al., 2002).

27

Cardiac Nav gating in adult and neonatal cardiomyocytes
While Nav1.5 is the primary current carrying sodium channel expressed in the
heart throughout development, previous studies suggested that there are
differences between neonatal and adult cardiac ventricular Nav gating (Zhang et
al., 1992). This report showed a large hyperpolarizing shift in the voltage
dependence of steady-state inactivation and an increase in the rate of
inactivation through development. It was speculated that the developmental
effects on channel inactivation were attributed to differential sympathetic
innervation. Similar results for changing rate of Na+ channel inactivation were
reported for chick embryo ventricle through development (Fujii et al., 1988).
Previous studies of cardiomyocytes have suggested that channel
glycosylation may impact heart function. In rabbit sino-atrial nodal cells and
ventricular myocytes, it was shown that treatment with neuraminidase resulted in
increased L and T-type Ca2+ current, suggesting that sialic acid is important in
the maintenance of proper cardiac cell Ca2+ permeability (Marengo et al.,
1998;Fermini & Nathan, 1991). Neuraminidase treatment of adult mouse
ventricular myocytes altered the voltage dependence and conductance of
transient outward K+ (Ito) and fast inward Na+ (INa) currents and reduced the
number of rat cardiac M2 muscarinic agonist-receptor complexes (Ufret-Vincenty
et al., 2001a;Ufret-Vincenty et al., 2001b;Haddad et al., 1990). Perhaps some of
the differences observed in cardiac Nav gating through development can be
attributed to changing levels of channel glycosylation.
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β interaction with α
In addition to the varying voltage-gated sodium channel α subunits that alone
comprise functional pore forming ion channels, there also exists auxiliary β
subunits often associated with α. There are currently four different β subunits,
and two splice variants, that have been identified to interact in one way or
another with the varying Nav α subunits of excitable tissues (Qin et al., 2003;Yu
et al., 2003;Kazen-Gillespie et al., 2000;Morgan et al., 2000;Isom et al.,
1995a;McClatchey et al., 1993;Isom et al., 1992). The main function(s) of β in
the body have yet to be fully understood but are thought to be any number of a
range of possible functions. In one study β1, β2, and β3 when co-transfected with
Nav1.2 (brain) in HEK293, resulted in Va and Vi, voltage of half-inactivation, being
shifted in the depolarized direction. β3 was also shown to increase persistent
sodium currents thought to increase the excitability of specific neuronal groups to
all of their input by amplifying synaptic summation (Qu et al., 2001). In contrast,
when co-transfected with Nav1.3 in CHO cells, β1 and β3 shifted Vi in the
hyperpolarized direction. Also, they observed no effect with β2 transfection alone
or in combination (Meadows et al., 2002a). β1-/- mice have been used to study
the abnormalities that occur in the absence of normal β1 expression. It was
noticed that the mice were ataxic with spontaneous seizures and altered levels of
expressed Nav1.1 and Nav1.3 in the absence of β1 suggesting a basis for epilepsy.
It was also suggested that β1, in these mice, was important in regulating Nav
density and localization with an implied role in axo-glial communication at nodes
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of Ranvier (Chen et al., 2004). It has also been suggested that β1 and β2 are cell
adhesion molecules that recruit ankyrin (Isom, 2001).
More specifically in the heart, Nav1.5 and various β subunits have also been
shown to interact. Using immunocytochemistry, Nav1.5, together with β1 and β2,
have been visualized at the intercalated disks (Maier et al., 2004). Another group
believes that tyrosine phosphorylation of β1 regulates its localization to the
intercalated disks (Malhotra et al., 2004). In the developing mouse heart, β1
mRNA levels were shown to increase at late embryonic and neonatal stages
being maximal in the adult with protein again visualized in the intercalated disks
(Dominguez et al., 2005). The β1 subunit is made up of a single transmembrane
spanning segment with an extracellular N-terminus (figure 10). The extracellular
portion of the protein contains four potential N-glycosylation sites and a single
immunoglobulin-like fold (Isom et al., 1992). In modulating Nav1.5 channel gating
it is generally noted that β1 co-expressed with α in various expression systems
causes a hyperpolarizing shift in the voltage dependence of channel activation
and inactivation (Johnson et al., 2004;Meadows et al., 2002a;Meadows et al.,
2002b;Meadows et al., 2001;McCormick et al., 1999;McCormick et al.,
1998;Chen & Cannon, 1995;Isom et al., 1995b;McClatchey et al., 1993).
However, β1 co-expression in HEK 293 cells, specifically, has resulted in
depolarizing shifts in Nav inactivation gating (Cummins et al., 2001;Dhar et al.,
2001;Qu et al., 2001). It is thought that at least three of the four N-linked
glycosylation sites are glycosylated, and are potentially capped by sialic acids
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Figure 10: Voltage-gated sodium channel β1 auxiliary subunit
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Figure 10: (continued)

The voltage-gated sodium channel β1 subunit is made up of a single membrane
spanning alpha helix with four predicted potential N-linked glycosylation sites.
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(Isom et al., 1992;Messner & Catterall, 1985). Could these sialic acids attached
to β1 be responsible for hyperpolarizing shifts observed in Nav1.5 gating?

Nav channel disorders

Voltage-gated sodium channels are vital for the proper initiation and
propagation of action potentials in the body. To reiterate, under normal
conditions, Nav experience three conformation changes that define its behavior.
Under hyperpolarized conditions the channel is in its closed resting state.
Membrane depolarization drives the channel into its open state allowing current
flow. Soon after opening and following membrane depolarization the channel
moves into the inactivated state blocking current flow. Then, following
membrane repolarization, the channel moves back to its resting state. When the
inactivation state of the channel comes on too slowly or incompletely then the
repolarizing phase of the action potential and the resting membrane potential
itself are altered potentially leading to disorders. In skeletal muscle, examples of
Nav disorders are paramyotonia congenita and hyperkalemic periodic paralysis
(Bouhours et al., 2005;Brancati et al., 2003;Lehmann-Horn et al.,
1987a;Lehmann-Horn et al., 1987b). In the central nervous system Nav
mutations have been implicated in epilepsies with a variety of phenotypes
including generalized epilepsy with febrile seizures plus (GEFS +), severe
myoclonic epilepsy in infancy (SMEI), intractable childhood epilepsy with
generalized tonic-clonic seizures (ICEGTC), and benign familial neonatal-infantile
seizures (BFNIS) (Nagao et al., 2005;Pineda-Trujillo et al., 2005;Yamakawa,
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2005;Kanai et al., 2004). In the heart Nav1.5 mutations have been implicated in
diseases such as Brugada syndrome, long QT syndrome, dilated
cardiomyopathy, arrhythmia, and conduction disorders (McNair et al.,
2004;Splawski et al., 2002;Bennett et al., 1995;Wang et al., 1995;Abriel et al.,
2001).
In addition to these disorders that are linked to various abnormalities
associated with the channel protein there are also a host of disorders linked to
irregularities in channel glycosylation. These disorders affect both N and Olinked glycosylation and are commonly referred to as congenital disorders of
glycosylation, or CDGs. There are twelve N-linked and four O-linked CDGs
affecting a wide range of ion channels in the body. Each of these CDGs are
caused by protein abnormalities, mostly enzymes, due to specific gene defects.
These many CDGs present themselves in a number of different phenotypes.
The O-linked CDGs are involved in four different abnormalities known as Ehlers–
Danlos syndrome (connective tissue disorder), multiple exostoses syndrome
(bone disorder of the epiphyseal plates), Walker–Warburg syndrome (lack of
normal folds of the brain, malformations of the cerebellum, abnormalities of the
retina, and progressive degeneration and weakness of the voluntary muscles),
and muscle–eye–brain disease (muscle weakness and a flaw in neuronal
migration resulting in a brain with a bumpy appearance and loss of normal
folding). The twelve different N-linked CDGs are separated into two groups. The
first group is described by eight assembling defects, labeled CDG-Ia to CDG-Ih,
and the second by four processing defects, labeled CDG-IIa to CDG-IId). These
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multiple CDGs in turn result in a number of defects such as hypotonia, failure to
thrive, developmental delays, hepatopathy, coagulopathy, esotropia, seizures,
cerebellar hypoplasia, ataxia, dysarthria, retinis pigmentosa, progressive scoliosis,
joint contractures, and absence of puberty in females (Marklova & Albahri, 2004;Jaeken,
2003;Marquardt & Denecke, 2003;Martin & Freeze, 2003;Grunewald et al., 2002). The

most common test used to diagnose a CDG is isoelectric focusing of serum
transferrin, which contains two N-linked glycosylation sites terminated with sialic
acids. When an abnormality is present, the protein is deficient in sialic acid,
which changes its IEF signature. Any of the CDGs that ultimately lead to Nav
sialic acid glycosylation deficiencies may have a direct effect on cellular
excitability.
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Materials and Methods

Construction of α and β cDNAs

The voltage gated cardiac sodium channel, Nav1.5, was kindly provided in
vector pRC-CMV (Invitrogen) by Dr. A. L. George Jr. The voltage gated sodium
channel beta subunit, hβ1, was subcloned into the bicistronic vector, pIRESEGFP (Clontech), to provide use of visual inspection to ensure β1 expression.

Pro5, Lec2 cell culture

Pro5 and Lec2 cells were grown in T25 flasks (Corning). Pro5 growth
medium consisted of αMEM (with ribo- and deoxyribonucleosides, Invitrogen)
and 10% FBS. Lec2 growth medium consisted of αMEM (without ribo- and
deoxyribonucleosides) and 10% FBS (Mediatech). Each growth medium also
contained 100 µg / ml-1 streptomycin and 100 U / ml-1 penicillin. Cells were
passaged once every three to four days. First, the growth medium was removed,
the cells were then rinsed once with PBS (Mediatech), and then 0.5 ml of trypsin
/ EDTA (0.05% / 0.53mM Mediatech) was added. The cells incubated in the
trypsin for about 30 seconds to 1 minute, then the flask was tapped to fully
dislodge the cells from the flask. To the 0.5 ml of trypsin was added 4.5 ml of the
appropriate growth medium to stop the reaction. Then, an appropriate volume of
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this cell suspension was added to a new T25 flask with enough growth medium
to equal 5 ml total.

Pro5, Lec2 cell transfection

Pro5, and Lec2 cell transfections were accomplished as previously described
(Johnson et al., 2004). Briefly, cells were seeded onto 35 mm dishes 24 hr
before use. The transfection mixture consisted of 1 ml of Opti-mem, 8 µl
lipofectamine (Invitrogen), and 2.0 – 2.5 µg DNA (90% hH1 α subunit vector and
10% pGreen Lantern Fluorescent Protein (GFP; Invitrogen) or β1 subunit vector)
in which the cells were incubated for 24 hr. The transfection mixture was
replaced with the appropriate growth media and the cells were then ready to use
48 hr later.

Pro5, Lec2 cell homogenization

Cells were first grown to confluence on 100 mm culture dishes. The media
was aspirated off and the cells were rinsed twice with ice cold PBS. Then, each
dish was incubated for five minutes with 1.5 ml of ice cold homogenization buffer
(20 mM tetrasodium pyrophosphate, 20 mM Na2PO4, 1 mM MgCl2, 0.5 mM
EDTA, 300 mM sucrose, 0.8 mM benzamidine, 1 mM iodacetamide, 1.1 µM
leupeptin, 0.7 µM pepstatin, 76.8 nM aprotinin). The cells were then scraped off
and ground in a dounce tissue grinder (40 strokes). The resulting suspension
was centrifuged for 5 minutes at 3,200g at 4˚C. The supernatant was then
centrifuged for 1 hour at 100,000g at 4˚C. The pellet was kept and then
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resuspended in 100 µl of fresh homogenization buffer and stored at -80˚C for
future use.

Neonatal and adult rat cardiomyocyte isolation and culture

Cardiomyocytes were isolated from male neonatal (3-5 days) and adult (10
week +) Sprague-dawley rats. The neonatal cardiomyocyte isolation protocol
was adapted from a method previously described (Isenberg & Klockner, 1982).
Neonatal rats were anaesthetized with pentobarbital sodium (200mg/kg). Atrial
or ventricular tissue was dissected out and washed in 0 Ca2+ Tyrode solution and
then separated into individual myocytes by immersion in 0.1% collagenase
(Sigma type I) solution for 0.5 hours, centrifuged for 5 minutes @ 160 g, then
retreated with fresh collagenase solution for 1 hour. The tissue was then
triturated to disperse the myocytes. The myocyte rich collagenase solution was
centrifuged @ 160 g for 5 minutes, rinsed with KB solution, centrifuged again,
and then plated with culture media. Adult ventricular and atrial myocytes were
isolated using a Langendorf perfusion protocol (7-10 ml / minute) adapted from a
method previously described (Saint et al., 1992). The adult rats were
anaesthetized with pentobarbital sodium (200mg/kg) and their hearts were then
dissected out. The whole hearts were first perfused with 0Ca2+ Tyrodes for five
minutes, then with 300 units/ml collagenase (Sigma type I) and 7 mg protease
(Sigma type XIV) in 0Ca2+ Tyrodes for 12 minutes, followed by 5 minutes of
perfusion with 0.1mmol/L Ca2+ Tyrodes. Atrial and ventricular tissue was then
cut down and triturated in 0.1mmol/L Ca2+ Tyrodes, run through a 200 µm filter,
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rinsed 3 times with culture media, and then plated. The growth media consisted
of DMEM (Mediatech) supplemented with 25 mM Hepes, 15% FBS, and 100 µg /
ml-1 streptomycin and 100 U / ml-1 penicillin.

Neonatal rat ventricular myocyte transfection

Neonatal rat ventricular myocytes were isolated and seeded onto 35 mm
dishes as previously described. The transfection mixture consisted of 6 µl
effectine (Qiagen) with 2 µg β1 subunit vector. The transfection mixture was then
added to a fresh 1 ml of growth media 3 hours after the cells were isolated. The
cells were then used for electrophysiology within 48 hr.

Cardiac tissue homogenization

First, the appropriate cardiac tissue was dissected out (atrial or ventricular),
rinsed of blood in ice cold PBS and placed into a 50 ml conical tube with 4 ml of
ice cold homogenization buffer. Using a Polytron homogenizer (Brinkmann
Instruments model #PT10/35) set at 10, the tissue was pulsed several times to
ensure complete homogenization. The homogenate was then stored at -80˚C for
future use.

Electrophysiology

Cells were studied using the patch clamp whole cell recording technique
previously described (Bennett, 2002;Bennett et al., 1997). Briefly, an Axon
Instruments 200B patch-clamp amplifier with a CV203BU headstage (Axon
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Instruments) was used in combination with a Nikon TE200 inverted microscope.
The pulse protocols were generated using a Pentium II computer (Dell
Computers) running pulse acquisition software (HEKA). The resulting analog
signals were filtered at 5 kHz using an eight-pole Bessel filter (9200 LPF;
Frequency Devices) and then digitized using the ITC-16 AD/DA converter
(Instrutech). A micromanipulator (MP-285 Sutter, Novato, CA, USA) was used to
place the electrode on the cell. Electrode glass (Drummond capillary tubes) was
pulled using a Sutter (model P-87) electrode puller to resistances of 1-2 MΩ.

Measuring Pro5, Lec2 Na+ currents

The external recording solution used consisted of: (in mmol/L) 224 sucrose,
22.5 NaCl (ph with NaOH), 4 KCl, 2.0 CaCl2, 5 glucose, and 5 Hepes. The
internal recording solution consisted of: (in mmol/L) 120 sucrose, 60 CsF, 32.5
NaCl (ph with NaOH), and 5 Hepes. All data was collected between 5-10
minutes after achieving whole cell configuration ensuring complete dialysis.
Series resistance was compensated from 95 - 98% for all the data.
Additionally, the smaller current produced by using the low sodium solutions
further minimized any remaining series resistance error, resulting in a <1 mV
error. Immediately prior to use, each solution was filtered using a 0.2 µm
Gelman filter. All experiments were performed at room temperature (~22oC).
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Measuring whole myocyte Na+ currents

The whole cell recording extracellular solution was: (in mmol/L) 5 NaCl, 10
TES, 5 KCl, 1 CaCl2, 5 CsCl, 10 glucose, 115 choline chloride. The electrode
solution consisted of (in mmol/L) 120 CsF, 10 TES, 2 MgCl2, 2 CaCl2, 5 NaCl, 20
EGTA. Both the ECF and ICF contained 20 NaCl for the neonatal myocyte ionic
strength experiments.
To ensure proper space clamping of the cardiomyocyte, several measures
were taken: 1) Data were analyzed from cells producing sodium currents of 7nA
or less, and reversing at the predicted sodium reversal potential. This required
solutions containing only 5 mM NaCl (adult cells cannot be clamped at 20 NaCl).
2) Only myocytes of 76 pF or less were analyzed, to ensure greater ease of
space clamp. 3) The slope of the G-V Boltzmann relationships were monitored,
and only cells in which the slope > 5 mV were analyzed. Any steeper slope
indicated a loss of voltage clamp. 4) All analyzed data were collected between 812 minutes after achieving whole cell configuration.
In addition to these precautions, all data were series resistance compensated
to 95 - 98%. If proper compensation was not achieved, the data were not
analyzed. Immediately prior to use, each solution was filtered using a 0.2 µm
Gelman filter. All experiments were performed at room temperature (~22oC).
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Pulse protocols for measuring whole cell Na+ currents

Pulse protocols were performed as described previously in Bennett, 2002
except that the holding potential used here was -120 mV (rat) and -100 (Pro5,
Lec2). Brief descriptions of the protocols follow.
Conductance-voltage (G-V) relationship

Cells were stepped for 10 ms from their respected holding potentials to
various depolarized potentials, ranging from -100 mV to +40 (rat) and +70 mV
(Pro5, Lec2) in 10 mV increments. Consecutive pulses were stepped every 1.5
seconds and the data were leak subtracted using the P/4 method, stepping
negatively from the -120 mV holding potential. At each test potential, steadystate whole cell conductance was determined by measuring the peak current at
that potential and dividing by the driving force (i.e., difference between the
membrane potential and the observed reversal potential). Peak conductance as
a function of membrane potential was plotted. The maximum sodium
conductance for a single cell was determined by fitting the data to a single
Boltzmann distribution (equation 1, solving for maximum conductance). The
average Va ± SEM and Ka ± SEM values were determined from these single
Boltzmann distributions. The normalized data were then averaged with those
from other cells, and the resultant average conductance-voltage curve was fit via
least squares using the following Boltzmann relation:
Fraction of maximal conductance = [1+(exp-(V-Va/Ka))]-1,

equation (1)

where V is the membrane potential, Va is the voltage of half activation, and Ka is
the slope factor.
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Steady-state inactivation curves (hinf)

Cells were first prepulsed for 500 ms from their respected holding potentials to
the plotted potentials ranging from -130 mV to -20 mV (rat) and +10 mV (Pro5,
Lec2) in 10 mV increments, then to +40 mV for 5 ms, then back to the -120 mV
holding potential. Currents from each cell were normalized to the maximum
current measured by fitting the data from a single cell to a single Boltzmann
distribution (equation 2, solving for maximum current), from which the mean Vi
+/- SEM and Ki +/- SEM values were determined. The normalized data for many
cells were then averaged and fit to equation (2), from which the mean voltage of
half inactivation (Vi) and slope factor (Ki) parameters for each cell type describing
steady-state inactivation for the channel population were calculated.
Fraction of maximum current = [1+(exp((V-Vi)/Ki))]-1

equation (2)

Measurement of inactivation time constants (τh)

Inactivation time constants for each cell type were determined by fitting to
single exponential functions the attenuating portions (90% - 10%) of the current
traces used to measure the G-V relationships.
Recovery from inactivation

Cells were held at their respected holding potentials, pulsed to +40 mV (rat) or
+60 mV (Pro5, Lec2) for 10 ms, and then stepped to the recovery potential for 1
to 20 ms in 1 ms increments. Following the recovery pulse, the potential was
again stepped to +40, or +60 mV for 10 ms. The peak currents measured during
the two +40, or +60 mV depolarizations were compared to determine the
fractional current measured during the second pulse.
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Desialylation of rat cardiomyocyte sodium channels

For desialylation experiments, cells plated onto 35 mm dishes were exposed
to 1.125 - 1.500 units neuraminidase (Sigma type X) / 1 ml DMEM for 3 hours.
Immediately following treatment, cells were rinsed with and allowed to recover in
their appropriate growth media at 3 - 5˚C for 0.5 hours to wash out enzyme and
quench further enzymatic reactions.

Deglycosylation of rat cardiomyocyte sodium channels

For deglycosylation experiments, cells plated onto 35 mm dishes were
exposed to 19 - 20 units PNGase-F (Sigma) / 1 ml DMEM for 12 hours.
Immediately following treatment, cells were rinsed with and allowed to
recover in their appropriate growth media at 3 - 5˚C for 0.5 hours to wash
out enzyme and quench further enzymatic reactions.

Antibody production and purification
α1Ab was produced as previously described (Bennett, 1999). Site-directed

polyclonal antibodies (α1Abs) were raised to an 18-mer peptide (pep-α1;
α Diagnostics) corresponding to the highly conserved III-IV linker region

(TEEQKKYYNAMKKLGSKK) in vertebrate sodium channels and were affinitypurified on a pep-α1-coupled column. β1Abs were raised to a 20-mer peptide,
GCLAITSESKENCTGVQVAE. Antibody concentrations were assayed using
optical density (O.D.) measurements at a 280-nm wavelength, with the accepted
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estimate that a 1.0 O.D. reading approximates 0.8 mg / ml α1Ab (Harlow & Lane,
1988).

Immunoblots

Cardiomyocyte homogenates were made by first harvesting the appropriate
tissues (neonatal and adult cardiac atrial/ventricular muscle). The tissue was
placed in ice cold sodium pyrophosphate buffer containing protease inhibitors
inhibitors (in mmol/L): 20 tetrasodium pyrophosphate, 20 Na2PO4, 1 MgCl2, 0.5
EDTA, 300 sucrose, 0.8 benzamidine, 1 iodacetamide, 1.1 leupeptin, and 0.7 µM
pepstatin and 76.8 nM aprotinin, and homogenized using a Polytron
homogenizer (Brinkmann Instruments model #PT10/35), set at 10, pulsed
several times to ensure complete homogenization, and then stored at -80˚C.

α

and β1 samples were mixed with sample buffer (10% glycerol, 5% 2mercaptoethanol, 3% SDS, 12.5% upper Tris buffer), denatured for 2 minutes in
boiled water, and then loaded into the lanes of a minigel cast from 4.5%
acrylamide. The gel was run for its full length at 75 - 100 V and then
electrophoretically transferred to nitrocellulose paper using a semi-dry transfer
cell (Biorad) for 22 minutes at 8 - 14 V. Cardiac sodium channel α and β1subunits were detected using a site-directed polyclonal antibody previously
described (α1Ab, β1Ab), (Bennett, 1999) then incubated with donkey anti-rabbit
horseradish peroxidase conjugated secondary antibody (Amersham) for 2 hours,
and visualized using a Pierce enhanced chemiluminescence kit. Immunoblot gel
shift analysis of the α-subunit under conditions of full and reduced sialylation
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were done by incubating homogenates with 1.35 units neuraminidase / 10 µg
protein for 3 hours at 37˚C. Complete deglycosylation was accomplished via
treatment with 20 units PNGase-F (Sigma) / 10 µg protein for 12 hours at 37˚C.

Data analysis

All electrophysiological data were analyzed using Pulse / PulseFit (HEKA) and
Sigmaplot 2001 (SSPS Inc.) software. Sigmagel (SSPS Inc.) software was used
to quantify the immunoblot data.
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Results

The ventricular Nav of the newborn gates at more depolarized potentials

The first step in attempting to determine the effects of channel sialylation /
glycosylation on gating is to collect control data. Whole cell currents similar to
that shown in Figure 11A were recorded from primary cultures of neonatal and
adult ventricular and atrial myocytes. Biophysical analyses of the sodium
currents revealed that neonatal and adult atrial and adult ventricular Nav gate
following smaller depolarizations than do neonatal ventricular Nav. Figures 11A
and B plot the steady-state activation (11A) and inactivation (11B) of the neonatal
and adult channels as a function of membrane potential. Both the Va and Vi for
the adult ventricle are 9 - 10 mV more hyperpolarized than those measured for
the neonatal ventricular channels. In addition, the Va and Vi for the atrial Nav are
similar to the adult ventricular Nav parameters (11A, B). Figure 11C shows the
fast inactivation time constants (τh) for each. Note that for the neonatal
ventricular Na+ current, τh generally is slower than for any of the other Nav. The
time to Nav recovery from fast inactivation, τrec, for all four samples is displayed in
figure 11D. τrec is slower for all atrial and adult ventricular Nav compared to the
neonatal ventricular Nav (11D). Collectively, these data reveal a consistent
chamber-specific difference in neonatal cardiac Nav voltage dependent gating,
and a developmental hyperpolarization in Nav gating in the ventricle.
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Figure 11: Whole cell recordings of isolated adult and neonatal atrial and

ventricular myocytes - determining voltage-dependent Nav gating characteristics
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Figure 11: (continued)

Circles: neonatal VCM. Squares: adult VCM. Triangles: neonatal ACM.
Inverted Triangles: adult ACM. Panel A: Steady-state activation (G-V
relationships). Inset: Whole cell Na+ current from an isolated adult VCM.
Currents were measured during test pulses of -100 to +40 mV in 10 mV
increments from the -120 mV holding potential. Panel B: Steady-state
inactivation (hinf). Data are the average peak current ± S.E.M. measured during
a 5 msec pulse to +40 mV following a 500 msec prepulse to the plotted
potentials. Inset: Whole cell Na+ currents measured during a series of +40 mV
test pulses, each following a prepulse to a larger depolarization ranging from
-130 mV to -20 mV in 10 mV increments.
panel C: Time constant of fast inactivation (τh). Data are the average τh ±

S.E.M. Curves are non-theoretical point-to-point. Inset: Current traces during a 50 mV test pulse. Solid traces: neonatal and adult ACM and adult VCM (NA,
AA, and AV, respectively). Dotted trace: neonatal VCM (NV).
Panel D: Voltage dependence of the recovery time constants (τrec). Data are

the average τrec ± S.E.M. Lines are non-theoretical point-to-point. Inset:
Plotted recovery data for all four conditions at a -130 mV recovery potential.
Curves are fits of the data to single exponential functions. Solid curves: NA, AA,
and AV. Dotted curve: NV.
For these and all remaining figures: NA (up arrows), AA (down arrows), NV
(circles), AV (squares).
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Gating of three of the four Nav types are sensitive to desialylation – only the
neonatal VCM Nav are insensitive

To determine whether the observed chamber-specific and developmental
shifts in Nav gating can be attributed to differences in functional channel sialic
acids, cells were desialylated by treatment with neuraminidase. Figure 12B
shows that, following neuraminidase treatment, the neonatal atrial channels are
sensitive to desialylation, with the Va shifting by 7 mV to more depolarized
potentials following neuraminidase treatment. However, identical treatment of
the neonatal ventricular Nav had no effect on Nav Va (12A). Desialylation of both
the adult atrial and ventricular Nav resulted in similar depolarizing shifts in Va
indicating a lack of adult chamber differences in contrast to that seen in neonate
(fig. 13). When studied from a developmental point of view, neuraminidase
treatment of adult ventricular Nav caused a significant 10 mV depolarizing shift in
Va (fig. 14B) when compared to the sialic acid insensitive neonatal ventricular Nav
Va (14A). Figure 15A and B show that both the neonatal and adult atrial
channels are sensitive to desialylation, with both Va shifting by approximately 7
mV to more depolarized potentials following neuraminidase treatment.
Desialylation similarly alters steady-state channel inactivation in a chamberspecific and developmentally dependent manner. Figure 16B shows a significant
5 mV depolarizing shift in neonatal atrial Nav Vi following desialylation, while
neonatal ventricular Nav Vi remains unaffected by treatment (16A). Desialylation
of both the adult atrial and ventricular Nav resulted in similar depolarizing shifts of
Vi demonstrating a lack of adult chamber differences in contrast to that seen in
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Figure 12: Desialylation of neonatal VCM and neonatal ACM Nav causes a

depolarizing shift in ACM steady-state Nav activation. Neonatal ventricular
channels are unaffected
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Figure 12: (continued)

G-V relationship for cardiomyocyte Nav ± neuraminidase. Data are the average
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits
of the data to single Boltzmann distributions.
Filled symbols: untreated. Open symbols: treated. Circles: neonatal VCM (A).
Triangles: neonatal ACM (B).
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Figure 13: Desialylation of adult VCM and adult ACM Nav causes a depolarizing

shift in steady-state Nav activation - both VCM and ACM channels are similarly
affected
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Figure 13: (continued)

G-V relationship for cardiomyocyte Nav ± neuraminidase. Data are the average
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits
of the data to single Boltzmann distributions.
Filled symbols: untreated. Open symbols: treated. Squares: Adult VCM (A).
Inverted triangles: Adult ACM (B).
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Figure 14: Desialylation of neonatal VCM and adult VCM Nav causes a

depolarizing shift in adult steady-state Nav activation - neonatal ventricular
channels are unaffected
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Figure 14: (continued)

G-V relationship for cardiomyocyte Nav ± neuraminidase. Data are the average
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits
of the data to single Boltzmann distributions.
Filled symbols: untreated. Open symbols: treated. Circles: neonatal VCM (A).
Squares: adult VCM (B).
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Figure 15: Desialylation of neonatal ACM and adult ACM Nav causes a

depolarizing shift in steady-state Nav activation - both neonatal and adult ACM
channels are similarly affected
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Figure 15: (continued)

G-V relationship for cardiomyocyte Nav ± neuraminidase. Data are the average
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits
of the data to single Boltzmann distributions.
Filled symbols: untreated. Open symbols: treated. Triangles: neonatal ACM (A).
Inverted triangles: Adult ACM (B).
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Figure 16: Desialylation shifts steady-state inactivation curves for neonatal atrial

Nav but has no effect on neonatal ventricular Nav inactivation
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Figure 16: (continued)

Channel availability (hinf) for cardiomyocyte Nav ± neuraminidase. Data are the
average normalized peak current ± S.E.M. measured during a 5 ms test pulse to
+40 mV following a 500 msec prepulse to the plotted potentials. Curves are fits
of the data to single Boltzmann distributions.
Filled symbols: untreated. Open symbols: treated. Circles: neonatal VCM (A).
Triangles: neonatal ACM (B).
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neonate (fig. 17). When developmentally studied, the Vi for adult ventricular Nav
is shifted by a depolarizing 13 mV with neuraminidase treatment (fig. 18B),
compared to the insensitive neonatal VCM Nav (18A). Figure 19A and B show
that desialylation results in similar depolarizing shifts on neonatal and adult atrial
Nav Vi, indicating no developmental shift in atrial Nav gating, in contrast to the
ventricle. The mean ± SEM values for all measured voltage dependent gating
parameters are listed in Table 1.

Sialic acids are responsible for faster inactivation kinetics - only neonatal
ventricular Nav inactivation shows no sialic acid sensitivity

As shown in Figure 11C above, data indicate that atrial and adult ventricular
Nav inactivate faster than neonatal ventricular Nav. When comparing neonatal
cardiac chambers, figure 20 shows a slowing of the rate of Nav fast inactivation
for neuraminidase treated neonatal atria and the neonatal ventricular Nav, again
showing no change with treatment. Neonatal ventricular Nav remain insensitive
to desialylation. Following neuraminidase treatment of the adult cardiac
chambers, desialylation resulted in comparable effects on Nav τh kinetics, unlike
in the neonate (fig. 21). When comparing the same chambers at two different
ages, desialylation of the ventricles indicates a developmental shift in Nav τh sialic
acid sensitivity (fig. 22). Desialylation of the atria reveals essentially no
developmental shift in Nav τh (fig. 23).
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Figure 17: Desialylation similarly shifts steady-state inactivation curves for both

adult ventricular and adult atrial Nav
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Figure 17: (continued)

Channel availability (hinf) for cardiomyocyte Nav ± neuraminidase. Data are the
average normalized peak current ± S.E.M. measured during a 5 ms test pulse to
+40 mV following a 500 msec prepulse to the plotted potentials. Curves are fits
of the data to single Boltzmann distributions.
Filled symbols: untreated. Open symbols: treated. Squares: adult VCM (A).
Inverted triangles: adult ACM (B).
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Figure 18: Desialylation shifts steady-state inactivation curves for adult

ventricular Nav but has no effect on neonatal ventricular Nav inactivation
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Figure 18: (continued)

Channel availability (hinf) for cardiomyocyte Nav ± neuraminidase. Data are the
average normalized peak current ± S.E.M. measured during a 5 ms test pulse to
+40 mV following a 500 msec prepulse to the plotted potentials. Curves are fits
of the data to single Boltzmann distributions.
Filled symbols: untreated. Open symbols: treated. Circles: neonatal VCM (A).
Squares: adult VCM (B).
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Figure 19: Desialylation similarly shifts steady-state inactivation curves for both

neonatal and adult atrial Nav
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Figure 19: (continued)

Channel availability (hinf) for cardiomyocyte Nav ± neuraminidase. Data are the
average normalized peak current ± S.E.M. measured during a 5 ms test pulse to
+40 mV following a 500 msec prepulse to the plotted potentials. Curves are fits
of the data to single Boltzmann distributions.
Filled symbols: untreated. Open symbols: treated. Triangles: neonatal ACM (A).
Inverted triangles: adult ACM (B).
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Figure 20: Sialic acid increases the rate of fast inactivation for neonatal atrial

Nav but has little effect on neonatal ventricular Nav inactivation rates
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Figure 20: (continued)

Time constant of fast inactivation (τh) as a function of membrane potential for
cardiomyocyte Nav ± neuraminidase. Data are the average τh ± S.E.M. Curves
are non-theoretical, point-to-point. Filled symbols: untreated. Open symbols:
treated. Circles: neonatal VCM (A). Triangles: neonatal ACM (B).
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Figure 21: Sialic acid causes an increase in the rate of fast inactivation for both
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Figure 21: (continued)

Time constant of fast inactivation (τh) as a function of membrane potential for
cardiomyocyte Nav ± neuraminidase. Data are the average τh ± S.E.M. Curves
are non-theoretical, point-to-point. Filled symbols: untreated. Open symbols:
treated. Squares: adult VCM (A). Inverted Triangles: adult ACM (B).
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Figure 22: Sialic acid increases the rate of fast inactivation for adult ventricular
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Figure 22: (continued)

Time constant of fast inactivation (τh) as a function of membrane potential for
cardiomyocyte Nav ± neuraminidase. Data are the average τh ± S.E.M. Curves
are non-theoretical, point-to-point. Filled symbols: untreated. Open symbols:
treated. Circles: neonatal VCM (A). Squares: adult VCM (B).
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Figure 23: Sialic acid causes an increase in the rate of fast inactivation for both
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Figure 23: (continued)

Time constant of fast inactivation (τh) as a function of membrane potential for
cardiomyocyte Nav ± neuraminidase. Data are the average τh ± S.E.M. Curves
are non-theoretical, point-to-point. Filled symbols: untreated. Open symbols:
treated. Triangles: neonatal ACM (A). Inverted Triangles: adult ACM (B).

75

Sialic acids act to slow the rate of recovery from fast inactivation for all but
the neonatal ventricular Nav

In line with the previously observed chamber-specific effects of Nav channel
sialylation on neonatal gating, figure 24B shows that neonatal atrial Nav τrec is
once more sensitive to neuraminidase treatment, the ventricular Nav are not (fig.
24A). Upon comparison of treated and untreated adult cardiac chambers, it is
noted that again the adult atrial and ventricular Nav τrec share similar sensitivities
to sialic acid, both becoming faster with treatment (fig. 25). It also seems
apparent that a developmental shift in channel sialylation also affects channel
τrec. When treated with neuraminidase the neonatal VCM Nav τrec was

consistently unaffected while the slower adult τrec became significantly faster and
more neonatal like (fig. 26). Furthermore, figure 27 demonstrates for a fourth
time a lack of a developmental shift in sialic acid sensitivity with respect to τrec
when moving from the neonatal to the adult atria, as witnessed with the
ventricles. Following desialylation, recovery time decreases for all but the
neonatal ventricular Nav.

PNGase-F treatment, removing N-linked glycosylation, results in no
significant difference in gating among all four tested Nav

Desialylation of the atrial and adult ventricular Nav via the use of
neuraminidase has consistently accounted for the vast majority of the differences
observed in atrial and adult ventricular Nav gating compared to the neonatal
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Figure 24: Recovery from fast inactivation for neonatal atrial Nav is faster

following desialylation - neonatal ventricular recovery rate is unaffected by sialic
acids
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Figure 24: (continued)

Voltage dependence of the inactivation recovery times for cardiomyocyte Nav ±
neuraminidase treatment. Data are the measured τrec as a function of recovery
potential. Lines are non-theoretical point-to-point.
Filled symbols: untreated. Open symbols: treated. Circles: neonatal VCM (A).
Triangles: neonatal ACM (B).
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Figure 25: Recovery from fast inactivation for adult ventricular and adult atrial
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Figure 25: (continued)

Voltage dependence of the inactivation recovery times for cardiomyocyte Nav ±
neuraminidase treatment. Data are the measured τrec as a function of recovery
potential. Lines are non-theoretical point-to-point.
Filled symbols: untreated. Open symbols: treated. Squares: adult VCM (A).
Inverted Triangles: adult ACM (B).
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Figure 26: Recovery from fast inactivation for adult ventricular Nav is faster

following desialylation - neonatal ventricular recovery rate is unaffected by sialic
acids
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Figure 26: (continued)

Voltage dependence of the inactivation recovery times for ventricular
cardiomyocyte Nav ± neuraminidase treatment. Data are the measured τrec as a
function of recovery potential. Lines are non-theoretical point-to-point.
Filled symbols: untreated. Open symbols: treated. Circles: neonatal VCM (A).
Squares: adult VCM (B).
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Figure 27: Recovery from fast inactivation for neonatal atrial and adult atrial Nav
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Figure 27: (continued)

Voltage dependence of the inactivation recovery times for atrial cardiomyocyte
Nav ± neuraminidase treatment. Data are the measured τrec as a function of
recovery potential. Lines are non-theoretical point-to-point.
Filled symbols: untreated. Open symbols: treated. Triangles: neonatal ACM (A).
Inverted Triangles: adult ACM (B).
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ventricular Nav. The reason for these differences may be due to the possibility
that likely more than just α subunit sialylation alone may be impacting channel
gating. A second, and simpler explanation may be due in part to inconsistent
desialylation of the Nav from sample to sample, experiment to experiment.
PNGase-F treatment of cardiac myocyte surface expressed Nav was employed to
remove sialic acids, and the remaining N-linked sugar structures, as a second
method to try and account for the remaining differences in gating seen after
neuraminidase treatment. Figure 28 provides a very clear and to the point
comparison of the tested PNGase-F treated atrial and adult ventricular Nav gating
parameters with that of the untreated and neuraminidase treated neonatal Nav
(no difference observed with PNGase-F treatment for neonatal VCM (curves not
shown)). When studying steady-state activation and inactivation it can be noted
that deglycosylation resulted in no differences between the atrial and adult
ventricular Nav Va and Vi compared to control and desialylated neonatal VCM
(figure 28A, B, Table 1). PNGase-F treatment of the atrial and adult ventricular
Nav also caused τh for these samples to slow to values insignificantly different to
those of the control and desialylated neonatal VCM (figure 28C). Additionally,
τrec for the deglycosylated atrial and adult ventricular Nav became significantly

faster, again resulting in virtually identical data for all four samples (figure 28D).
In conclusion, these data strongly support the idea that the majority of observed
differences between control atrial and adult ventricular Nav, compared to that of
control neonatal VCM, could be attributed to differences in channel sialylation,
with channel deglycosylation accounting for the remainder.
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Figure 28: Deglycosylation of atrial and adult ventricular Nav results in gating

characteristics nearly identically to those of neonatal ventricular Nav

B
Normalized Current

1.00
0.75
0.50
0.25
0.00
-100

-80

-60

-40

-20

1.00
0.75
0.50
0.25
0.00

0

-140

Membrane Potential (mV)

-120

-100

-80

-60

Prepulse Potential (mV)

D
Recovery Time Constant (ms)

C
Inactivation Time Constant (ms)

Normalized Conductance

A

10
8
6
4
2
0
-60

-50

-40

-30

-20

-10

12
10
8
6
4
2
0
-140

-130

-120

Recovery Potential (mV)

Membrane Potential (mV)

86

-40

Figure 28: (continued)

Panel A: steady-state activation. Panel B: steady-state inactivation. Panel C:
fast inactivation kinetics. Panel D: recovery from fast inactivation kinetics. All of
the data shown for adult ACM/VCM and neonatal ACM Nav is following treatment
with PNGase-F (open symbols), and the neonatal VCM Nav is under control
(solid circles) and neuraminidase treated (dotted, open circles) conditions.
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The atrial and adult ventricular Nav α subunit is apparently more heavily
sialylated than the neonatal ventricular Nav

Figures 12 - 28 indicate that gating of the atrial and adult ventricular Nav are
more sensitive to desialylation than is neonatal ventricular Nav gating. One
possibility is that the neonatal ventricular Nav is the least sialylated of the
channels, with differential sialylation occurring throughout the developing
ventricle and between the newborn’s atria and ventricle. To test this possibility, a
series of immunoblots were run to measure the apparent molecular weight (Mr) of
Nav α subunits as expressed in the four cardiomyocyte types. Homogenates of
atria and ventricles harvested from newborn and adult rats were run on 4.5 %
SDS-PAGE gels, blotted, and challenged with the α subunit Nav antibody, α1Ab.
From these blots, it was apparent that the atrial and adult ventricular Nav α
subunits were similar in Mr, and were consistently heavier than the neonatal
ventricular channel (Figure 29A). The average measured Mr for the atrial and
adult ventricular α subunit was 251.8 +/- 0.6 kD (n=41), while the average Mr for
the neonatal ventricular α subunit measured 246.5 +/- 0.8 (n=19). Thus, the
atrial and adult ventricular Nav α subunits were about 5 kD larger on average
than the neonatal ventricular Nav α subunit. Because the Mr observed for all four
homogenates is significantly greater than the predicted Mr for unprocessed
Nav1.5, (about 227 kD), the data indicate that all four channel types are
glycosylated, with the neonatal ventricular channel less processed than the other
three channel types.
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Figure 29: Gel shift analyses indicate that channel sialylation increases

throughout the developing ventricle and is greater in the atria versus ventricle of
the newborn
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Figure 29: (continued)

Bands detected using αAb at a 1:200 concentration. Lane labels: NV: neonatal
ventricle. AV: adult ventricle. NA: neonatal atria. AA: adult atria.
Panel A: Immunoblot of ACM and VCM at two developmental stages. Lanes 1,

4, and 7: Molecular weight markers. 5µg protein loaded per lane.
Panel B: Immunoblot of ACM and VCM ± PNGase-F treatment. Lanes 1, 6, and

11: Molecular weight markers. 5µg protein loaded per untreated lane, 10µg
protein loaded per treated lane.
Panel C: Immunoblot of ACM and VCM ± neuraminidase treatment. Lanes 1, 6,

and 11: Molecular weight markers. 5µg protein loaded per untreated lane, 10µg
protein loaded per treated lane.
Panel D: Bar graph of average measured Nav α subunit Mr for each

homogenate ± PNGase-F ± neuraminidase. Each bar represents the mean Mr ±
SEM measured for a series of immunoblots. Dark bars: Untreated. Light bars:
PNGase-F treated. Gray bars: Neuraminidase treated. SA: Sialic acid. The
number of samples measured is listed at the base of each bar. Significance was
determined for the untreated data using a two-tailed student’s t-test comparing
the atrial and adult ventricular α subunit Mr to the neonatal ventricular α subunit
Mr. ** = Highly significant (P < 0.01)
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To determine more directly whether changes in channel glycosylation are
responsible for the observed differences in Mr, myocyte homogenates were
treated with the enzyme, PNGase-F. PNGase-F removes N-linked glycosylation
at the site of protein attachment. In figure 29B, Mr for all four PNGase-F treated
homogenates was reduced to 231.1 ± 0.9 kD (n=20), with no significant
difference in Mr measured among the homogenates following PNGase-F
treatment. Thus, these data strongly indicate that the neonatal ventricular Nav is
~5 kD less N-glycosylated than the other channel types tested.
To examine whether the differences in glycosylation levels observed are due
to increases in α subunit sialylation, myocyte homogenates were treated with
neuraminidase to remove sialic acids specifically. As shown in Figure 29C, the
measured Mr for all homogenates was reduced following neuraminidase
treatment, suggesting that all cardiac Nav types are sialylated. Consistently, the
predicted α subunit Mr for all four homogenates were reduced to similar levels
following neuraminidase treatment, indicating that the atrial and adult ventricular
channels are more sialylated than the neonatal ventricular channel. Figure 29D
illustrates the average Mr measured for each Nav under control, PNGase-F, and
neuraminidase treated conditions (listed in Table 2). The graph shows that the
untreated Mr for the atrial and adult ventricular channels are nearly identical,
while the Mr for the untreated neonatal α subunit is significantly lower. PNGaseF and neuraminidase treatment results in a similar Mr for all four channel types,
indicating that a difference in channel sialylation is primarily responsible for the
differences in Nav Mr observed. On average, the sialic acid dependent Mr
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(change in Mr with neuraminidase treatment) for the neonatal ventricular Nav α
subunit is about 5.3 kD, while the average SA-dependent Mr for the other three
channel α subunits is a much larger, 9.1 kD. Direct comparison of the SAdependent shift in Mr for neonatal VCM versus the other three channel types
produced a highly significant, 3.8 +/- 0.4 kD difference (n=23), all of which can be
assigned to channel sialic acids. This 3.8 kD of sialic acids (a 72 % increase
from neonatal VCM to ACM and adult VCM) added throughout the developing
ventricle and between chambers of the newborn heart is consistent with about 15
more sialic acid residues attached to the atrial and adult ventricular Nav α
subunits.

Increased functional sialylation of atrial and adult ventricular Nav account
for most of the hyperpolarizing shifts in channel gating

The immunoblot gel shift analyses shown above indicate that the neonatal
ventricular Nav α subunit is the least sialylated among the four tested
cardiomyocyte α subunits. As shown in Figures 11-28, the neonatal ventricular
channel consistently gates following larger depolarizations compared to the
voltage dependent gating of the other channel types. Further, gating of the atrial
and adult ventricular Nav all shifted to more depolarized potentials following
desialylation, while gating of the neonatal ventricular channel was unaffected.
Figure 30 compares the voltage dependent parameters measured for each
channel type ± desialylation / deglycosylation. Note that none of the measured
neonatal ventricular Nav gating parameters was significantly altered by
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Figure 30: Functional channel sialic acids can account for much of the
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Figure 30: (continued)

Bar graphs of the measured voltage-dependent Nav gating parameters for each
myocyte type ± neuraminidase. Each bar represents the average measured
parameter ± S.E.M. All values and significance listed in Table 1. Black bars:
control. Light gray bars: neuraminidase treated. Dark gray bars: PNGase-F
treated. NA: neonatal atria. AA: adult atria. NV: neonatal ventricle. AV: adult
ventricle.
Panel A: Voltage of half activation (Va)
Panel B: Voltage of half inactivation (Vi)
Panel C: Time constant of inactivation (τh) measured during a -50 mV test pulse.
Panel D: Time constant of recovery from inactivation (τrec) measured at a –120

mV recovery potential.

94

desialylation / deglycosylation. However, following desialylation /
deglycosylation, all measured gating parameters for the atrial channels, both
neonatal and adult, as well as the adult ventricular channel, shifted to
depolarized potentials, similar in value to those measured for the neonatal
ventricular Nav.

Nav1.5 expressed with β 1 in Pro5 versus Lec2 indicates β 1 action on Nav1.5
gating is sialic acid dependent

In order to directly compare the effects of β1 sialylation on Nav1.5 channel
gating, the Pro5 / Lec2 CHO cell expression system was used. Pro5 and Lec2
cells are related CHO cells that produce proteins with differing amounts of
posttranslationally attached sialic acids (Deutscher et al., 1984;Stanley,
1985;Stanley, 1989). The Pro5 cell is essentially a CHO cell allowing for normal
protein sialylation. The Lec2 cell is deficient in the CMP-sialic acid transporter
thus sialic acid cannot enter the Golgi and be added to proteins.
When Nav1.5 was expressed alone in either of the two cells, whole cell
recording indicated that none of the four tested gating parameters (Va, Vi, τh, τrec)
was significantly different from one cell to the other (see Bennett, 2002 for
details). This indicates that in the Pro5 / Lec2 cell expression system Nav1.5
gating is not significantly affected by α subunit sialylation. That is, the added α
subunit sialylation accomplished by the Pro5 cell is not sufficient to alter channel
gating when compared to the Lec2 cell. To test whether β1 has an effect on
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Nav1.5 channel gating and if those effects are sialic acid dependent, the Nav1.5 α
subunit was co-expressed with β1 in both Pro5 and Lec2 cells.
Figure 31 indicates that when the α and β1 subunits were co-expressed into
the Lec2 cells there was no difference in channel activation, Va (fig 31A), or
channel inactivation, Vi (fig 31B), when compared to the α subunit alone. When
co-expressed in the Pro5 cells, both Va and Vi were shifted in the hyperpolarized
direction by 9 and 11 mV respectively. These data indicate that β1’s influence on
Nav1.5 steady-state activation and inactivation is sialic acid dependent.
The kinetics of channel inactivation and recovery from inactivation were
studied next. Figure 32A and B show that the Nav1.5 α subunit τh and τrec were
unaffected when co-expressed with β1 in Lec2 cells. Similar to Va and Vi, when α
and β1 were co-expressed in Pro5 cells, τh was faster and τrec was slower. β1
sialic acids are indicated to be responsible for the observed changes in τh and
τrec. Together, steady-state and kinetic data gathered from α and β1 co-

expression experiments in Pro5 versus Lec2 cells indicate that β1 modulation of
Nav1.5 gating appears to be sialic acid dependent. All of the values can be found
in Table 3.
In a final attempt to demonstrate that β1’s influence over Nav1.5 gating is sialic
acid dependent, β1 was mutated to remove all four N-glycosylation sites through
site-directed mutagenesis. Removal of all four N-glycosylation sites thus
removes all sialic acid from the protein. When co-expressed with Nav1.5 in fully
sialylating Pro5 cells, the β1 mutant failed to affect Va, similar to wild-type β1 co96

Figure 31: β1 sialic acids cause a hyperpolarizing shift in Nav1.5 activation and

inactivation
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Figure 31: (continued)

Filled Squares / Solid Lines: α transfected into Pro5 cells. Filled Circles / Solid
Lines: α transfected into Lec2 cells. Filled Squares / Dashed Lines: β1 cotransfected with α in Pro5 cells. Open Squares / Dashed Lines: β1 co-transfected
with α in Lec2 cells.
Panel A: Steady-state activation (G-V relationships). Data are the average peak

current ± S.E.M. at a membrane potential and the curves are fits of the data to
single Boltzmann relationships.
Panel B: Steady-state availability (hinf) curves. Data are the mean normalized

peak current ± S.E.M. measured during a maximally depolarizing test pulse
following a 500 msec prepulse to the plotted potentials.
(Johnson et al., 2004)
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Figure 32: β1 sialic acids increase the rate of fast inactivation while decreasing

the rate of recovery from fast inactivation
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Figure 32: (continued)

Filled Squares / Solid Lines: α transfected into Pro5 cells. Filled Circles / Solid
Lines: α transfected into Lec2 cells. Filled Squares / Dashed Lines: β1 cotransfected with α in Pro5 cells. Open Squares / Dashed Lines: β1 co-transfected
with α in Lec2 cells.
Panel A: Time constant of fast inactivation (τh). Data are the average τh ±

S.E.M. as a function of membrane potential. Curves are non-theoretical point-topoint..
Panel B: Voltage dependence of the recovery time constants (τrec). Data are

the average τrec ± S.E.M. at a -140, -130, and -120 mV recovery potential. Lines
are non-theoretical point-to-point.
(Johnson et al., 2004)
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expressed with α in Lec2 cells. Proper surface expression of the β1 mutant was
confirmed by tagging with GFP (see Johnson et al., 2004 for details). The
addition of the β1 mutant data strongly indicates that β1 modulation of Nav1.5 is
sialic acid dependent.

SDS-PAGE analysis indicates good expression and glycosylation of β 1
using the Pro5 / Lec2 mammalian expression system

In order to verify the expression of β1 in transfected Pro5 and Lec2 cells,
immunoblot analyses of homogenized transfected Pro5 and Lec2 cells were run.
Figure 33 compares β1 transfected Pro5 and Lec2 cells to those of GFP
transfected controls. Lanes 2 and 5 show GFP transfected Lec2 and Pro5,
respectively, and there is an obvious lack of a band in the predicted 22 - 37 kd
range as previously described (Patton et al., 1994;Sutkowski & Catterall, 1990).
Lanes 1 and 4 shows β1 transfected Lec2 and Pro5, respectively, with each lane
showing a clear band in the 22 - 37 kd range indicating good β1 expression
throughout.

Transfection with β 1 fails to modulate neonatal ventricular Nav gating

To determine if the difference in Na+ channel gating in the developing
ventricle is a β1-induced phenomenon, neonatal VCM were transfected with β1.
Whole cell recordings studying Va and Vi for the transfected neonatal VCM were
compared to that of untransfected controls. Preliminary data indicates that
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Figure 33: Immunoblot of β1 transfected into Lec2 and Pro5 cells
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Figure 33: (continued)

Lane 1 is β1 transfected into Lec2 cells. Lane 2 is GFP transfected control in
Lec2 cells. Lane 3 is a molecular weight marker lane. Lane 4 is β1 transfected
into Pro5 cells. Lane 5 is GFP transfected Pro5 cells. Bands detected using
β1Ab at a 1:200 concentration.
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transfection of β1 has no significant effect on neonatal ventricular Nav Va (fig.
34A). This experiment also demonstrates the same lack of effect on Vi with β1
transfection (fig. 34B). Is it possible that, for some unknown reason at the
studied age that β1 is not properly interacting with α on a physical level, or, could
the apparently reduced capacity of the neonatal ventricle to sialylate proteins be
responsible for the lack of effect of transfected β1 on Nav gating, similar to β1
expressed in Lec2?

SDS-PAGE analysis indicates adult ventricular expression of β 1 exceeds
that of atria and neonatal ventricle

Our recent work has implicated the β1 sialic acids to be its primary modulatory
tool of action on various Nav gating parameters (Johnson et al., 2004).
Immunoblot analysis of neonatal and adult rat ventricular and atrial homogenates
were done to observe the relative amount of β1 present in each of the four
samples for comparative analysis. In figure 35, lanes 2, 3, 4, and 5 are neonatal
ventricle, adult ventricle, neonatal atria, and adult atria, respectively. It is clear
that in a side-by-side comparison the adult ventricle possesses more β1 protein.
The other three samples also contain trace amounts of β1. In the ventricle, β1
appears to be up regulated with development and differentially expressed
between cardiac chambers.
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Figure 34: Preliminary results indicate that β1 transfection has no significant

impact on neonatal VCM Nav activation or inactivation, potentially due to a lack of
β1 subunit sialylation
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-20

Figure 34: (continued)

Filled Circles: Untransfected neonatal VCM. Open Circles: Neonatal VCM
transfected with β1.
Panel A:

G-V relationships for neonatal VCM ± β1.

Data are the average

normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits
of the data to single Boltzmann distributions.
Panel B: Channel availability (hinf) for neonatal VCM ± β1. Data are the average

normalized peak current ± S.E.M. measured during a 5 ms test pulse to +40 mV
following a 500 msec prepulse to the plotted potentials. Curves are fits of the
data to single Boltzmann distributions.
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Figure 35: Immunoblot of β1 in neonatal and adult ventricle and atria
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Figure 35: (continued)
β1 protein is most prominent in the adult ventricle when compared to the less

dense bands seen in neonatal ventricle/atria and adult atria.
Lane labels: NV: neonatal ventricle. AV: adult ventricle. NA: neonatal atria. AA:
adult atria. Lane 3 is a molecular weight marker. Bands detected using β1Ab at
a 1:200 concentration.
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Discussion

Differential sialylation of the α subunit is a major contributor to
developmental shifts in ventricular Nav gating not observed in atria

Comparison of Nav gating measured from neonatal and adult ventricle
indicated that the adult channel gates at potentials about 10 mV more
hyperpolarized than does the neonatal channel. In addition, neonatal and adult
atrial Nav were tested and, in contrast to ventricle, gated at similar potentials to
each other and adult ventricle. More importantly, this demonstrated a difference
in Nav channel gating between neonatal atria and ventricle not seen in the adult.
In response to these differences, I sought to explore what might be responsible
for this Nav remodeling observed throughout development and between cardiac
chambers. It was hypothesized that development- and/or chamber- dependent
changes in the amount of channel associated functional sialic acids might
account for these observed shifts in gating. Neuraminidase treatment was used
to remove sialic acids from the cell surface expressed Nav of the ventricular and
atrial cardiomyocytes. None of the tested voltage dependent gating parameters
for the neonatal ventricular Nav was affected by neuraminidase treatment. When
treated, all of the atrial and adult ventricular Nav gating parameters shifted to
more depolarized potentials similar in value to those measured for untreated (or
treated) neonatal ventricular Nav. Also, neuraminidase treatment resulted in no
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significant change in the channel activation slope values, Ka, for any of the tested
conditions. This implies no consequence of desialylation on the effective valency
of the channel S4 gating charges that move in response to the changing electric
field. As a result, desialylation apparently alters the electric field sensed by the
channel gating charges, not the charges themselves. These results provided
strong evidence that sialic acids, as part of N-glycosylation trees attached to the
Nav channel, are responsible for the observed differences in gating.
To determine whether sialic acids are fully responsible for the gating
differences observed between myocyte chambers and ages, desialylation was
achieved via removal of the entire N-linked glycosylation trees attached to the
channel. Removal of N-linked sugars through PNGase-F treatment (Figure 28)
indicated that all gating parameters for atrial and adult ventricular channels
behaved nearly identically to those measured for the neonatal ventricular
channel. Similar to what was seen with neuraminidase treatment, PNGase-F
treatment again resulted in no significant change in Ka for any of the tested
conditions. This indicates no additional outcome of deglycosylation on the
effective valency of the channel S4 gating charges that move in response to the
changing electric field. The data suggest that the differences in Nav gating
between neonatal heart chambers, and throughout ventricular development, can
be accounted for by differential glycosylation, with changes in functional sialic
acid levels being the most important. That is, functional sialic acids can account
for the majority of voltage-dependent gating differences observed, while removal
of the full N-glycosylation structures can account for all measured shifts among
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Nav. It is possible that two distinct N-glycosylation dependent mechanisms are
responsible for the hyperpolarizing shifts in Nav gating. However, it is more likely
that while neuraminidase treatment consistently removes functional sialic acids, it
may not have removed all functional sialic acids for each cell studied, while
PNGase-F treatment was much more effective. If this were the case, the
observed SA-dependent effects on gating would be underestimated, resulting in
measured parameters that apparently did not fully shift with desialylation.
To strengthen the electrophysiological evidence, biochemical analysis was
done to determine if atrial and adult ventricular Nav are more heavily sialylated
than neonatal ventricular Nav. Immunoblot analysis of the neonatal and adult
atria and ventricular Nav α subunits revealed that the neonatal ventricular Nav
was lighter in weight than the other three. When the homogenates were exposed
to PNGase-F, the resultant immunoblot weights for all four samples were now
similar to each other, and to the predicted unprocessed weight of Nav1.5
indicating no difference in isoform expression. These results allow us to
conclude that the initial difference in Mr observed for the four conditions is due to
differences in posttranslational modification. When treated with neuraminidase,
gel shift analysis indicated that approximately 15 more sialic acid residues are
attached to the atria and adult ventricular Nav than the neonatal ventricle. These
data are consistent with the biophysical measurements, suggesting that most of
the differences in gating between neonatal ventricular Nav and the Nav expressed
in atria and adult ventricle are the result of fewer functional sialic acids attached
to the neonatal ventricular α subunit. According to these findings the number,
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and possibly location, of functional sialic acid residues added to cardiac Nav are
regulated as a function of cardiac development and chamber. Potentially this
difference is due to changes in the activity level of many of the different
sialyltransferase enzymes throughout development.

Chronic versus acute channel regulation

Differential sialylation may potentially modulate Nav gating through two
different mechanisms, acute or chronic. In the case of acute regulation, various
Nav α subunits, which are differently glycosylated / sialylated, might be
expressed at various periods in the life of an excitable cell. This difference in Nav
α subunit sialylation may directly and differently alter channel gating and cellular

excitability. As previously noted, the primary neonatal and adult cardiac Nav α
subunit isoform is believed to be the same gene product (Nav1.5). However, the
primary neonatal skeletal muscle Nav α subunit is Nav1.5 while the primary adult
skeletal muscle Nav α subunit is the Nav1.4 isoform (Cohen & Barchi,
1993;Messner & Catterall, 1985;Miller et al., 1983). In addition, it was shown that
the adult skeletal muscle α subunit isoform is more heavily glycosylated than the
neonatal skeletal muscle α subunit isoform (Cohen & Levitt, 1993;Zwerling et al.,
1991;Kraner et al., 1989;Gordon et al., 1988;Roberts & Barchi, 1987). To
compare these two different Nav isoforms, a study comparing the sialic acid
dependent gating of the heavily glycosylated Nav1.4 to the lesser glycosylated
Nav1.5 in two types of CHO cell lines was done. When expressed in Pro5 cells
(fully sialylating CHO cells) versus Lec2 cells (sialylation deficient CHO cells) it
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was shown that Nav1.4 gating is much more sensitive to sialic acids than is Nav1.5
gating. The study went on to localize the functional sialic acid residues to the
IS5-S6 loop of Nav1.4 (Bennett, 2002). Thus, channel gating appears to be
partially dependent on the “glycosylation signature” of the α subunit expressed.
This means that skeletal muscle cells, at different periods in their development,
may be differently excitable, dependent upon which Nav α subunit is expressed
at the time. This demonstrates how the number and / or location of sialic acids
indeed vary from one α subunit to another, producing a potential spectrum of
functional sialic acids among Nav α subunits that may directly and differently
modulate channel gating acutely.
The data shown here are consistent with a second “chronic” mechanism by
which differential channel sialylation modulates Nav gating. In the case of
chronic regulation, the glycosylation signature of the expressed channels of the
cell are not modified through the expression of different α subunit isoforms,
rather via changes in the level of sialyltransferase activity with respect to a single
α subunit isoform. Altered transferase activity would lead to altered levels of

channel functional sialic acids thus affecting cellular excitability. We show here
that ventricular Nav gating shifts in the hyperpolarized direction with
development, which can be abolished with neuraminidase treatment. Using
biochemical means it was shown that in the adult ventricle the Nav α subunit is
apparently more heavily sialylated than the neonatal ventricular α subunit. These
data are consistent with a chronic increase in sialyltransferase activity in the
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developing ventricular cardiomyocytes. Also, a higher level of sialyltransferase
activity in the neonatal atria versus ventricle can explain the increase in atrial α
subunit functional sialylation. Recently, our laboratory has had Gene Chip
analysis performed on mouse atrial and ventricular myocytes done at neonatal
and adult ages. These data have yielded results consistent with our idea of
chronic regulation. In detail, the up regulation of sialyltransferase expression in
the developing ventricle and between chambers of the neonatal heart was shown
to be apparent. With increased sialyltransferase activity, more functional sialic
acids might be added to the α subunit, directly modulating the voltage at which
atrial and developing ventricular Nav gate.

Control of Nav gating by differential sialylation appears to be intra and inter
tissue specific

Differential channel sialylation appears to be a mechanism by which cardiac
Nav activity may be modulated throughout development or between cardiac
chambers. A recent study of Nav1.9 function in rat dorsal root ganglia, also
reported developmental regulation of channel sialylation. This study from the
Waxman laboratory indicated that an apparent decrease in Nav1.9 sialylation
through development as expressed in dorsal root ganglion (DRG) neurons was
responsible for a depolarizing shift in the half-inactivation voltage for Nav1.9.
More heavily sialylated neonatal Nav1.9 inactivated at more hyperpolarized
potentials than did the adult Nav1.9. Channel activation voltage was unaffected by
this differential sialylation (Tyrrell et al., 2001). Additionally, NCAM is an example
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of another protein, not a voltage-gated ion channel, which is differentially
sialylated throughout development, similarly to Nav1.9 becoming less sialylated
with age. Reports have indicated that the highly polysialylated neonatal NCAM,
with its decreased adhesive function, serves to maintain the integrity of the
developing neuroepithelium, while in the adult, the less polysialylated highly
adhesive NCAM is used to stabilize the differentiated neural structures in the
adult (Breen & Regan, 1988;Sunshine et al., 1987;Mccoy et al., 1985;Finne,
1982;Hoffman et al., 1982;Rothbard et al., 1982). Importantly, this is good
evidence to support a possible role of sialic acid in modulating the actions of
different elements in multiple unrelated processes. Additionally, these reports
and the data shown here lead to a rather provocative and novel finding: chronic
differential sialylation evidently modulates Nav gating throughout development in
a tissue- and intra-tissue (cardiac atria vs. cardiac ventricle) specific manner.
The NCAM research showed that the differential sialylation of NCAM
throughout the developing neuroepithelium appeared to be vital in the correct
construction of the neural pathways. The DRG study showed that only channel
inactivation voltage was affected by apparently lower levels of sialic acid
attached to the adult Nav1.9. Here, the data indicate that adult ventricular Nav are
apparently more heavily sialylated than neonatal ventricular Nav. As a result of
this increased sialylation, all tested voltage dependent gating parameters were
shown to gate at more hyperpolarized potentials. Speaking strictly of voltagegated ion channels, the opposing changes in Nav1.9 and Nav1.5 sialylation
throughout the development of two different cell types suggest that channel
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gating may be modulated chronically through enzyme regulated tissue-specific
differential sialylation. Furthermore, a lack of changing sialylation with atrial
development suggests that the same isoform may be differently chronically
regulated, or not, within the same organ system as well. Here we observed
essentially uniform hyperpolarizing shifts in all gating parameters with increased
sialylation for adult ventricular Nav1.5 while the DRG study reported non-uniform
depolarizing shifts for the lesser sialylated adult Nav1.9. Therefore, in addition,
these observations suggest that the modulation of Nav gating through chronic
differential sialylation may be isoform-specific as well.

Acute regulation of Nav gating via β 1 expression

When one considers how the addition of other elements, such as auxiliary
β subunits interacting with α subunits, and the additional sialic acids they may

also bring to the area can affect channel gating, the situation can become even
more complicated. Nav1.5 has been shown to interact with β1 and β2 in the heart
(Maier et al., 2004;Malhotra et al., 2004). The effects of channel sialylation, more
specifically on the Nav individual subunits, α and β1, that can be expressed
together were examined in two ways. It was hypothesized that the β1 sialic acids
may further exert a modulatory effect on channel gating through a novel transregulatory mechanism. To do this the Nav1.5 α subunit was expressed with β1 in
fully- and non-sialylating CHO cells and β1 alone in neonatal VCM. The
expression system studies showed that all of the measured effects of β1 on
116

channel gating were due to β1 sialic acids (Johnson et al., 2004). Data gathered
after transfecting β1 into neonatal rVCM revealed no change in gating from
untransfected conditions. This can possibly be explained in two ways, either the
transfected β1 subunit did not interact with Nav1.5, or the lesser Nav sialylating
neonatal rVCM also fails to fully sialylate β1 thus rendering it nonfunctional.
Throughout various excitable tissues it has been shown that β1 processing and
expression appears to be developmentally regulated (Sashihara et al.,
1996;Sashihara et al., 1995;Yang et al., 1993;Sutkowski & Catterall, 1990). This
potential use of auxiliary β subunits is another example of chronic and acute
channel modulation via differential sialylation. Changing levels of overall channel
sialylation through changing levels of sialyltransferase activity will impact β
subunits chronically, thus regulating channel gating. At the same time, regulation
of β expression levels may directly impact the level of overall channel associated
sialic acids acutely regulating channel gating. As a result of this regulation of β
subunit sialylation, the excitability of the cell may be affected in a more controlled
manner, producing a wide range of differentially sialylated Nav. Unfortunately,
the inability to identify in native cells the α/β complexes in real time, while
studying Nav function in real time is a major hurdle in determining the total impact
of such varying subunit combinations in vivo. Perhaps the use of a fluorescent
tagged antibody specific for β1 can be used to at least confirm, or not, the surface
expression of β1 following expression in transfected cardiac myocytes.
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Potential physiological impact of increased or decreased sialylation and
future experiments

Here it is shown that functional sialic acids added to the developing ventricular
Nav α subunit directly alter channel gating. In addition, neonatal atrial Nav have a
greater level of functional sialic acids than do neonatal ventricular Nav. What
might be the physiological role for such developmental and spatial remodeling?
There are at least two mechanisms by which sialic acid dependent shifts in Nav
gating might modulate cardiac Na+ channel activity such that the spreading
depolarizing/repolarizing waves across the heart would be affected: 1) A
hyperpolarizing shift and slight increase in the window current, and 2) A
significant slowing of the rate of recovery from fast inactivation.
The distribution of channels between the open and inactivated states at a
membrane potential affects the percentage of channels that are persistently
active. This distribution can be represented graphically by overlapping G-V and
steady-state inactivation curves, and is referred to as the “window current”
(Attwell et al., 1979). The intersecting area under the curves represents the
voltage range at which a small percentage of channels may be persistently
active. There are several reports that show point mutations of SCN1A and
SCN5A cause depolarizing shifts in the voltage range of the window current that
may be responsible for such maladies as epilepsy and arrhythmias (LQTS)
(Spampanato et al., 2003;Abriel et al., 2001;Splawski et al., 2002). It has been
proposed that changes that act to depolarize the window current, either through
subunit mutation or desialylation, can lead to LQTS by creating persistent inward
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sodium current later in phase 2. This inward current will then act against the
beginning delayed rectifier outward current, extending phase 2 of the
cardiomyocyte action potential and, therefore, increasing the L-Q time period.
For the atrial and adult ventricular Nav, the window current will be about 10 mV
more hyperpolarized than the neonatal ventricular Nav window current, caused
by the sialic acid dependent hyperpolarizing shifts in the G-V and hinf curves for
atrial and adult ventricular Nav. This will cause persistent atrial and adult
ventricular Nav activity to occur at more hyperpolarized potentials, thus impacting
cardiomyocyte excitability in a positive fashion. Potentially this may serve to
create a more easily excitable cell, thus protecting the integrity of the spreading
action potential, while, at the same time protecting the cells from LQTS
abnormalities.
The sialic acid dependent slowing of the rate of recovery from fast inactivation
likely directly affects cardiac excitability. It is observed here that atrial and adult
ventricular Nav recover from fast inactivation more slowly than do the neonatal
ventricular Nav. Also, atrial and adult ventricular Nav recovery rates increase with
desialylation to values close to or faster than neonatal ventricular Nav recovery
rates, indicating that the slower recovery rates are due to an increase in
functional sialic acids. This slower recovery rate will alter the effective time
between successive depolarizing / repolarizing waves because of the
redistribution of Nav among functional states toward a larger population of
inactivated channels. That is, at a short time following the initialization of a Nav
kinetic cycle, the percentage of atrial and adult ventricular Nav still in the
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inactivated state will be greater than the percentage of inactivated neonatal
ventricular channels, thus extending the absolute refractory period. This will
directly affect the rate at which subsequent depolarizations might lead to
activation of significant Nav. Because a larger percentage of atrial and adult
ventricular Nav remain inactivated for longer periods of time, these slower
recovery rates will act to limit early after depolarizations (EADs), often considered
a leading cause of tachycardias. One study, published by Chen et al., showed
that certain SCN5A mutations that cause familial idiopathic ventricular fibrillation,
IVF, was the result of a 25-30% increase in the Nav1.5 rate of recovery at a -80
mV recovery potential (Chen et al., 1998). In this study, desialylation results in
an even greater increase in sodium channel rates of recovery from inactivation
than those resulting from the aforementioned SCN5A mutations. Normally, as an
action potential is propagated to the left and right ventricles the signal that meets
in the middle is cancelled out due to the left and right ventricular myocytes now
being in their respective refractory periods. In the case of unidirectional
conduction block, myocytes distal to the damaged area causing the block have
not been excited by the myocytes proximal to the block. As a result, the normally
cancelled out signal is now allowed to propagate from the myocytes distal of the
block to the proximal myocytes. Under normal conditions the proximal cells are
in their refractory periods, thus preventing reentry through the damaged area of
the heart. Under abnormal conditions resulting either from mutation or, in this
case, reduced channel sialylation, the proximal myocytes, having recovered
faster than normal from inactivation, fail to prevent reentry of the signal leading to
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circus movement and potentially fatal ventricular fibrillation. Thus, increased
sodium channel sialylation leads to slower rates of recovery from fast
inactivation, which will effectively slow the Nav kinetic cycle. This will directly
affect whether and what percentage of Nav from an individual myocyte will
activate in response to the depolarizing / repolarizing waves propagating across
the heart, thereby impacting heart rhythms. Thus, the majority of changes in
ventricular Nav gating throughout development and the difference in the
newborn’s atrial and ventricular Nav gating can be attributed to differential
channel sialylation that directly modulates cardiac voltage-gated sodium channel
gating.
A physiological role for sialic acids in cardiomyocyte excitability has been
demonstrated in a recent study (Ufret-Vincenty et al., 2001a). Cardiac excitability
and Nav gating were studied using a heart failure mouse model, a knockout of
the muscle LIM protein (MLP). When wild type ventricular myocytes were treated
with neuraminidase they produced Na+ currents that gated similarly to those of
untreated MLP-/- myocytes, which are apparently less sialylated. This suggests
that the observed extended action potential repolarization of the MLP-/- myocyte
was caused in part by lesser sialylated Nav. The knockout and neuraminidase
treated wild type myocyte Nav both experienced a reduction and rightward shift in
their window current. In addition, the rate of fast inactivation was slowed for
desialylated and MLP-/- myocytes. Each of these gating effects is consistent with
those described here for the SA-insensitive neonatal ventricular Nav, and for all
desialylated conditions. The authors concluded that the lesser sialylated Nav of
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the MLP-/- myocytes might be responsible for the extended action potential
duration and increased susceptibility to EADs observed in this study.
Thus, differential sialylation of Nav will likely impact cardiac excitability through
one or more of the mechanisms described herein. Increased Nav sialylation
leads to slower rates of recovery from fast inactivation, effectively extending the
refractory period, which should lower susceptibility to EADs. Furthermore, the
SA-dependent leftward shift in window current has been implicated in limiting
action potential duration. Consequently, increased sialylation may cause the
initial wave of excitation to occur at smaller depolarizations, while serving to also
limit and control subsequent excitability, thus acting to help modulate and
regulate heart rhythm.
It is important to realize that this work is merely a small piece of the puzzle
that describes cardiac excitability. It has been shown that sialic acid
glycosylation may be a strong modulator of cardiac Nav gating. In this study the
primary means used to test sialic acid’s influence on gating was with
neuraminidase to remove cell surface expressed sialic acid residues, and
PNGase-F to remove the N-glycosylation altogether. Other substances, for
example swainsonine or castanospermine, that prevent the addition of sialic
acids to the protein from inside the cell may also be used as another means to
desialylate Nav. Other methods that can be used, similar to this idea of
preventing sialylation first rather than removing it later, would be through the use
of sialyltransferase deficient knock out mouse models. Not only could such
knock out studies investigate specifically the effects of sialic acid on cardiac ion
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channels, it could also allow for observations of phenotypic maladies that
manifest due to the sialic acid deficiency. It is true that without voltage-gated
sodium channels there would be no fast response phase 0 and essentially no
cardiac action potential. However, it is impossible to contemplate the cardiac
action potential without thinking about the other ion channels involved, potassium
and calcium channels. The cardiac iK+ is generated by a combination of inward
rectifier, delayed rectifier, and transient outward voltage-gated K+ channels. Ltype voltage-gated Ca2+ channels generate the cardiac iCa2+ forming the myocyte
phase 2 plateau, and are responsible for the slow response phase 0 in nodal
pacemaker cells. To understand the impact of sialic acid on cardiac excitability
we must first understand its impact on these voltage-gated K+ and Ca2+ channels
too. Future electrophysiological and biochemical studies, similar to the ones
done here, investigating the biophysical effects of, and relative levels of
functional sialic acids on these individual channels can be done. Once
completed, the individual sialylated vs. unsialylated data for each ion channel can
be compiled and perhaps used to run cardiac simulations comparing the two
conditions to each other. Action potential measurements done on
cardiomyocytes before and after desialylation may further provide more data that
can help answer some of the questions regarding the true purposes behind ion
channel glycosylation.
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Summary

Here we see first hand the potential effects of ion channel sialylation with
regards to channel gating and cellular excitability. In this example there appears
to be a consistent trend in biophysical properties for cardiac Nav when comparing
fully sialylated to lesser sialylated channels. In all tested biophysical parameters
the existence of greater levels of functional sialic acids acted to create a more
readily excitable cell while also appearing to serve a protective function for the
heart against various electrical conduction and physical pumping pathologies. It
is possible that the atrial Nav are fully sialylated at birth to continually ensure a
readily excitable atria providing for maximal ventricular filling to be accomplished
in the allotted time before ventricular contraction, a desired optimal result at any
atrial age. At the same time the lesser sialylated conditions of the neonatal
ventricle, serving to increase recovery from inactivation, may facilitate the more
rapid basal heart rate of the smaller neonatal heart. In the adult heart the reason
for fully sialylated atrial Nav probably remains similar to that for the neonate. In
the adult ventricle, however, this increase in functional channel sialylation, when
compared to the neonate, may in fact serve to increase the excitability of the
myocytes aiding in the production of ventricular systole. At the same time, due to
the substantial increase in necessary conduction length in the larger ventricles,
increased functional sialylation may likely aid in the prevention of the action
potential from degrading before it fully spreads throughout the ventricles. Finally,
and possibly most importantly, increased adult ventricular Nav functional
sialylation, through its resultant decrease in Nav rates of recovery from
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inactivation, may help to prevent electrical disturbances of the ventricles that may
otherwise result in the death of the animal.
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Table 1. Gating parameters for adult and neonatal cardiomyocyte Nav under

conditions of full and reduced sialylation / glycosylation
Va

Vi

τh @ -50 mV

τrec @ -120 mV

(mV)

(mV)

(msec)

(msec)

11

-46.1 ±1.0

-87.8 ±1.5

4.0 ±0.2

7.9 ±0.3

Neonatal VCM
Neuraminidase

11

-46.8 ±1.0

Neonatal VCM
PNGase-F

6

Adult VCM
Untreated

Cell

n

Neonatal VCM
Untreated

#

#

#

-88.7 ±1.2
#

#

4.9 ±0.4
#

#

7.9 ±0.6
#

-49.5 ±1.5

-90.6 ±1.1

3.6 ±0.3

8.4 ±0.6

8

**
-56.9 ±1.1

**
-97.1 ±2.7

**
2.8 ±0.1

**
13.7 ±1.9

Adult VCM
Neuraminidase

8

a**; b

a**; b

a**; b

-47.3 ±1.6

-83.8 ±2.1

4.7 ±0.7

Adult VCM
PNGase-F

7

Neonatal ACM
Untreated

#

#

#

#

#

#

a**; b**
5.4 ±0.7
#

a**; b

a**; b

a**; b

a**; b

-48.3 ±2.0

-86.7 ±2.6

3.7 ±0.5

7.6 ±0.7

17

**
-57.0 ±0.6

**
-100.0 ±0.7

**
2.2 ±0.1

**
18.1 ±1.2

Neonatal ACM
Neuraminidase

13

a**; b

a*; b**
-95.4 ±1.8

a**; b**
3.2 ±0.2

a**; b**
13.2 ±1.7

Neonatal ACM
PNGase-F

6

Adult ACM
Untreated

#

-49.9 ±1.1
#

#

#

#

a**; b

a**; b

a**; b

a**; b

-47.2 ±2.0

-86.3 ±2.0

4.5 ±0.6

8.0 ±0.9

13

**
-56.7 ±1.0

**
-96.7 ±1.5

**
2.0 ±0.1

**
14.5 ±1.5

Adult ACM
Neuraminidase

11

a**; b
-49.9 ±1.0

#

a**; b**
3.3 ±0.2

a**; b
9.7 ±0.8

Adult ACM
PNGase-F

7

a**; b
-50.0 ±1.0

#

a**; b
3.0 ±0.3

#

a**; b
-91.3 ±0.9

#

a**; b
-88.8 ±1.9

#

#

#

a**; b
9.9 ±1.2

The mean gating parameter values ± SEM are listed. Significance was
determined using a two-tailed student’s t-test comparing sample groups as
follows: 1) Untreated samples were compared to untreated neonatal VCM, 2)
Treated samples were compared to: a) their untreated cell type, and b) neonatal
VCM.

#

= Not significant. * = Significant (P < 0.02). ** = Highly significant (P <

0.01).
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Table 2. Gel shift analyses for neonatal and adult cardiomyocyte sodium

channels under conditions of full and reduced glycosylation / sialylation

Cell

n

Untreated

n

PNGase-F

n

Neuraminidase

Neonatal
Ventricle

19

246.5 ±0.8

6

**
231.6 ±1.9

13

**
241.2 ±0.7

Adult
Ventricle

18

**
251.8 ±1.2

6

**
231.3 ±2.0

12

**
242.0 ±1.1

Neonatal
Atria

12

**
252.2 ±0.5

4

**
230.2 ±1.1

8

**
243.1 ±0.6

Adult
Atria

11

**
251.4 ±0.4

4

**
230.7 ±1.2

7

**
243.3 ±0.5

Data list the mean Mr +/- SEM measured for neonatal and adult cardiomyocyte
Nav α subunits. For the untreated data and their comparison to the treated
homogenates, significance was determined using a two-tailed student’s t-test
comparing the atrial and adult ventricular α subunit Mr to the neonatal ventricular
α subunit Mr. ** = Highly significant (P < 0.01).

127

Table 3: Gating parameters for Nav1.5 transfected with or without β1 in the fully

sialylating Pro5 or sialylation deficient Lec2 mammalian cell lines

Cell

n

Va
(mV)

Vi
(mV)

τh @ -40 mV
(ms)

τrec @ -120 mV
(ms)

Pro5 + α

13

-29.0 ±2.2

-78.7 ±2.5

2.8 ±0.4

4.0 ±0.1

Lec2 + α

10

-29.5 ±1.6

-79.5 ±1.9

2.4 ±0.2

4.1 ±0.1

Pro5 + α + β1

11

**
-37.4 ±1.6

*
-86.1 ±3.2

*
2.0 ±0.1

**
5.6 ±0.3

Lec2 + β1

9

-28.6 ±0.9

-78.8 ±1.6

2.9 ±0.2

4.1 ±0.1

The data are the mean parameter values ± S.E.M. Significance was tested using
a two-tailed student’s t-test, with each condition being compared to that
measured for the fully sialylated α subunit alone. ** = highly significant (p <
0.005). * = significant (p < 0.1).
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